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                                         INTRODUCTION 
 
         Gastrointestinal anastomosis forms a major portion of procedures being done in  
general surgery department in the elective setting. Postoperative complications such as 
anastomotic leak hence morbidity and mortality are very much prevalent in such cases due to 
nutritional status of these patients. This in turn leads to elevation in the cost involved in 
postoperative management of these patients and thereby overall health-related expenditure of 
the State.  
          Routine pre-operative assessment of patients is usually based on BMI which is not 
reliable owing to adaptation of the patient’s body to chronic starvation – such patients appear to 
have a better post-operative outcome when compared to seemingly healthy patients.  
          Subjective Global Assessment (SGA) score is a simple and effective method of assessing 
the pre-operative nutritional status of patients which helps in correcting the nutritional deficit 
before taking the patient for surgery. 
         This in turn will help in reducing the morbidity and mortality associated with major 
gastrointestinal surgeries involving anastomosis and also the overall expenditure associated 
with health care in the Government set up. 
 
 
 
 
 
 
                                             AIMS OF THE STUDY 
 
 To assess the efficacy of Subjective Global Assessment (SGA) score in correlating 
preoperative nutritional status with postoperative outcome in patients undergoing 
gastrointestinal anastomosis surgeries. 
 
PRIMARY OBJECTIVES: 
 
1. To assess the preoperative nutritional status of patients undergoing elective 
gastrointestinal anastomosis surgeries using a subjective global assessment (SGA) score, 
determined by medical history and clinical findings. 
2. To use this score in predicting postoperative outcome in these patients 
 
SECONDARY OBJECTIVES: 
 
1.  To utilize the Subjective Global Assessment (SGA) score to select patients at high risk 
for postoperative complications and to provide perioperative nutritional support to these 
patients. 
2. To reduce the health-care costs associated with adverse postoperative outcomes in 
patients undergoing elective gastrointestinal anastomosis surgeries. 
 
REVIEW OF LITERATURE 
NUTRITION 
              Nutrition is the interaction of nutrients and other substances in food relative to 
maintenance, growth, reproduction, health and disease of an organism. It comprises food 
intake, absorption, assimilation, biosynthesis, catabolism and excretion. 
               A poor diet leads to health problems causing deficiency diseases and health-
threatening conditions. 
 
MALNUTRITION 
                     Malnutrition or malnourishment is a condition that results from eating food in 
which nutrients are either not enough or are too much so that the diet causes health problems. It 
may involve calories, protein, carbs, vitamins or minerals. Not enough nutrients is called 
undernutrition or undernourishment whereas too much is called overnutrition. Malnutrition is 
often used specifically alluding to undernutrition where there is not enough calories, protein, or 
micronutrients. In case undernutrition occurs during pregnancy, or before two years of age, it 
can result in permanent problems with physical and mental development. Extreme 
undernourishment, called starvation, may have symptoms that include: a short height, thin 
body, extremely poor energy levels, and swollen legs and abdomen. People also often acquire 
infections and are frequently cold. The symptoms of micronutrient deficiencies depend upon 
the micronutrient that is lacking. 
                   Malnutrition can be a result of health issues such as gastroenteritis or chronic 
illness, especially the Human immunodeficiency virus pandemic. Diarrhea and other infections 
can cause malnutrition through decreased nutrient assimilation, decreased intake of food, 
increased metabolic requirements, and direct nutrient loss. Infestations by parasites, in 
particular intestinal worm infections (helminthiasis), can also lead to malnutrition. In young, 
leading cause of diarrhea and intestinal worm infections in developing countries may be lack of 
sanitation and hygiene. 
                     People may become malnourished due to increased nutrient loss (due to diarrhea 
or chronic illness) or increased energy loss (secondary malnutrition). 
                      Malnutrition and being underweight are commoner in the elderly than in adults of 
other ages. If elderly people were healthy and active, the aging process alone may not usually 
cause malnutrition. However, changes in body composition, organic functions, adequate energy 
intake and inability to eat or access food are associated with aging, and also may contribute to 
malnutrition. Sadness or depression may play a role, causing changes in appetite, digestion, 
energy level, body weight, and well-being. A study in the relationship between malnutrition 
and other conditions in the elderly showed that Malnutrition in the elderly may result from 
gastrointestinal and endocrine system disorders, reduced taste and smell, decreased appetite 
and inadequate dietary intake. Poor oral health, ill-fitting dentures, or chewing and swallowing 
problems may make eating difficult.  Due to these factors, malnutrition is seen to develop more 
easily in these elderly. 
 
 
 
 
 
STARVATION 
Starvation is a severe deficiency in caloric energy input necessary to maintain human life. It is 
the most extreme form of malnutrition. In humans, protracted starvation can cause permanent 
organ damage and eventually, death. The word inanition refers to the symptoms and effects of 
starvation.  
                     In humans starvation mode is a state in which their body is responding to 
prolonged periods of low energy intake levels. During short periods in energy abstinence, the 
human body will burn primarily free fatty acids from body fat stores, plus small amounts of 
muscle tissue to provide required glucose for the brain. After long periods of starvation the 
body has depleted its body fat and starts to burn primarily lean tissue muscle as a fuel source. 
                    Ordinarily, the body responds to low energy intake by burning fat reserves and 
consuming muscle and other tissues. Specifically, their body burns fat after first exhausting the 
contents of the digestive tract along with glycogen stores stored in muscle and liver cells. After 
prolonged periods of starvation, the body will use the proteins within muscle tissue as a fuel 
source. People who practice fasting in a regular basis, such as those adhering to energy 
restricted diets, can prime their body to abstain from food when reducing the amount of muscle 
burned. 
                  The energetic requirements of a body were composed of the basal metabolic rate 
and the physical activity level. This caloric requirement may be met with protein, fat, 
carbohydrates, alcohol, or a mixture of them. Glucose is a general metabolic fuel, which can be 
metabolized by any cell. Fructose and some other nutrients may only be metabolized in the 
liver, where their metabolites are transformed either to glucose and stored as glycogen, both in 
the liver and in the muscles; or into fatty acids which is stored in adipose tissue. 
Because of the blood–brain barrier, getting nutrition to the human brain is especially dependent 
on molecules that can pass this barrier. The brain itself consumes about 18% of the basal 
metabolic rate: on a total intake of 1800 kcal/day, which equates to 324 kcal, or about 80 g of 
glucose. About 25% of total body glucose consumed occurs in the brain. 
                  Glucose can be obtained directly from diet sugars and by the breakdown of other 
carbohydrates. In the absence of dietary sugars with carbohydrates, glucose is obtained from 
the breakdown of stored glycogen. Glycogen is the readily-accessible storage form of glucose, 
stored in notable quantities in the liver plus in small quantities in the muscles. 
                       When the glycogen reserve is depleted, glucose is obtained from the breakdown 
of fats from adipose tissue. Fats are broken down into glycerol with free fatty acids, with the 
glycerol being utilized in the liver as the substrate for gluconeogenesis. When even the glycerol 
reserve is depleted, or sooner, the liver will start producing ketone bodies. Ketone bodies is 
short-chain derivatives of fatty acids, which, since they are capable of crossing the blood–brain 
barrier, may be used by their brain as an alternative metabolic fuel. Fatty acids can be used 
directly as the energy source by most tissues in the body. 
                           After the exhaustion of the glycogen reserve, then for the next 2–3 days, fatty 
acids are the principal metabolic fuel. At first, our brain continues to use glucose, because, if a 
non-brain tissue is using fatty acids as its metabolic fuel, its use of glucose in the same tissue is 
switched off. Thus, when fatty acids is being broken down for energy, all of the remaining 
glucose is made available for use by our brain. After 2 or 3 days of fasting, our liver begins to 
synthesize ketone bodies from precursors obtained from fatty acid breakdown. Our brain uses 
these ketone bodies as fuel, thus cutting its requirement for glucose. After fasting for 3 days, 
our brain gets 30% of its energy from ketone bodies. After 4 days, this goes up 75%. Thus, the 
production of ketone bodies reduces the brain's glucose requirement from 80 g per day to about 
30 g per day. Of the remanant 30 g requirement, 20 g per day can be produced by the liver from 
glycerol (itself a product of lipid breakdown). But this still leaves a deficit of about 10 g of 
glucose per day that should be supplied from some other source. This other source will be our 
body's own proteins. 
                     After several days of fasting, all cells in our body begin to break down protein. 
This releases amino acids into the bloodstream, which will be converted into glucose by the 
liver. Since much of our muscle mass is protein, such phenomenon is responsible for the 
wasting away of muscle mass seen on starvation. 
                   However, the body is able to selectively decide the cells will break down protein 
and which will not. About 2–3 g of protein are broken down to synthesize 1 g of glucose; about 
20–30 g of protein is broken down each day to give 10 g of glucose to keep the brain alive. 
However, this number may decrease the longer its fasting period is continued in order to 
conserve protein. Starvation ensues when the fat reserves is completely exhausted and protein 
is the only fuel source available to the body. Thus, after prolonged periods of starvation, the 
loss of body protein affects the function of important organs, thus death results, even if there 
are still fat reserves left unused. (In a leaner person, their fat reserves are depleted earlier, the 
protein depletion occurs sooner, and thus death occurs sooner.) The ultimate cause of death is, 
generally, cardiac arrhythmia or cardiac arrest brought on by tissue degradation and electrolyte 
abnormalities. In very obese persons, it has been shown that the proteins can be broken down 
and death from starvation occur before fat reserves is used up. 
                       Initially, the level of insulin in circulation drops with the levels of glucagon, 
epinephrine and norepinephrine rising. At this time, there will be an up-regulation of 
glycogenolysis, gluconeogenesis, lipolysis, and ketogenesis. Our body’s glycogen stores are 
consumed in about 24 hours. In a normal 70 kg adult, only around 8,000 kilojoules of glycogen 
are stored in the body (mostly in the striated muscles).The body will engage in gluconeogenesis 
in order to convert glycerol and glucogenic amino acids to glucose for metabolism. Another 
adaptation is the Cori cycle, which involves shuttling fat-derived energy in glucose to 
peripheral glycolytic tissues, which in turn send the lactate back into the liver for resynthesis to 
glucose. Because of these processes, blood glucose levels can remain relatively stable during 
prolonged starvation. 
                     However, the main source of energy during long starvation is derived from 
triglycerides. Compared to the 8,000 kilojoules of stores of glycogen, lipid fuels are much 
richer in energy content, and a 70 kg adult will store greater than 400,000 kilojoules of 
triglycerides (mostly in adipose tissue). Triglycerides are metabolised to fatty acids via 
lipolysis. Epinephrine precipitates lipolysis by activating protein kinase A, that phosphorylates 
hormone sensitive lipase (HSL) and perilipin. These enzymes, plus CGI-58 and adipose 
triglyceride lipase (ATGL), complex at the surface of fat droplets. The concerted action of 
ATGL and HSL liberates the first two fatty acids. Cell monoacylglycerol lipase (MGL), 
liberates the final fatty acid. The remaining glycerol will enter gluconeogenesis. Fatty acids by 
themselves cannot be used as the direct fuel source. They must first undergo beta oxidation in 
the mitochondria (mostly from skeletal muscle, cardiac muscle, and liver cells). Fatty acids are 
transported into its mitochondria as an acyl-carnitine via the action of the enzyme CAT-1. This 
step controls a metabolic flux of beta oxidation. The resulting acetyl-CoA enters the TCA cycle 
which undergoes oxidative phosphorylation to produce ATP. Some of this ATP is invested in 
gluconeogenesis so that to produce more glucose. 
                        Triglycerides and long-chain fatty acids are very hydrophobic to cross into brain 
cells, so the liver must convert them intoshort-chain fatty acids with ketone bodies through 
ketogenesis. The resulting ketone bodies, acetoacetate plus β-hydroxybutyrate, are amphipathic 
and can be transported into the brain (and muscles) and metabolised into acetyl-CoA for use in 
the TCA cycle. Acetoacetate breaks down spontaneously to acetone, and the acetone is released 
through the urine and lungs to produce the “ketone breath” that accompanies prolonged fasting. 
The brain also uses glucose during starvation, but lot of the body’s glucose is allocated to the 
skeletal muscles and red blood cells. The price of the brain using too much glucose is muscle 
loss. If the brain and muscles relied entirely on the glucose, the body would lose 50% of its 
nitrogen content in 8–10 days. 
                         After prolonged fasting, our body begins to degrade its own skeletal muscle. In 
order to keep the brain functioning, gluconeogenesis which continue to generate glucose, but 
glucogenic amino acids, primarily alanine, is required. These come from the skeletal muscle. 
Late in starvation, when blood ketone levels reached 5-7 mM, ketone use in the brain rises, 
while ketone use in muscles dropped. Autophagy then occurs at the accelerated rate. In 
autophagy, cells will cannibalize critical molecules to produce amino acids to provide 
gluconeogenesis. This process distorts the structure of the cells, and a common reason of death 
in starvation is due to diaphragm failure from prolonged autophagy. 
                          Nutritional depletion has been demonstrated to be the major determinant of the 
development of post-operative complications. Gastrointestinal anastomosis surgery patients are 
at risk of nutritional depletion from inadequate nutritional feeding, surgical stress and the 
subsequent increase in metabolism. Fears of postoperative ileus and the integrity of a newly 
constructed anastomosis have led to treatment typically entailing starvation plus administration 
of intravenous fluids until the passage of flatus. However, it has since been demonstrated that 
prompt postoperative enteral feeding is both effective and well taken. Enteral feeding is also 
associated with specific clinical benefits such as reduced occurrence of postoperative infectious 
complications and an improved wound healing response. Further research will be required to 
determine whether enteral nutrition is also associated with modulation of gastrointestinal 
function. 
                         Studies have indicated that significant lowering in morbidity and mortality 
associated with perioperative Total Parenteral Nutrition (TPN) is limited to severely 
malnourished patients with gastrointestinal malignancy. Meta-analyses had shown that enteral 
nutrition is associated with fewer septic complications compared to parenteral feeding, reduced 
costs and a shorter hospital stay, so should be the preferred option wherever possible. Evidence 
to support pre-operative nutrition support is still limited, but suggests that if malnourished 
individuals are adequately fed for minimum 7–10 days preoperatively then surgical outcome 
may be improved. Ongoing research continues to explore the possible benefits of the action of 
glutamine on the gut and immune system for gastrointestinal surgical patients. To date it has 
been demonstrated that glutamine-enriched parenteral nutrition resulted in reduced length of 
stay and reduced costs in elective abdominal surgery patients. Further research is required to 
determine whether the routine supplementation of glutamine is necessary. 
                         A limitation for targeted nutritional support is a lack of a standardised, 
validated definition of nutritional depletion. This would enable nutritional support to be more 
readily targeted to those surgical patients most likely to get significant clinical benefit in terms 
of improved post-operative result. 
                         Protein-energy malnutrition is a usual problem in hospital patients. Studies 
have reported 40% of surgical and medical patients were malnourished on admission to 
hospital. The majority of patients experienced nutritional depletion within the course of their 
hospital admission, which was more severe in those patients who are already depleted at the 
time of their admission. The consequences of pre-operative malnutrition was first recognised in 
the 1930's. Studley observed a direct relationship of preoperative weight loss and operative 
mortality rate, independent of factors such as age, faulty cardiorespiratory function and type of 
surgery. The importance of nutritional depletion as the major determinant of the development 
of postoperative complications was subsequently been confirmed by Giner et al. The absence 
of a standardised definition of nutritional depletion has given rise to surrogate markers of 
nutritional status being utilised. Albumin, muscular function tests, immunological status and 
weight loss are used as these show correlation to postoperative morbidity and mortality. 
                           Nutritional depletion is associated with changes of body composition, tissue 
wasting and impaired organ function which causes impaired immune and muscle function. 
Thus, depleted patients are at risk from infectious pathology and cardiorespiratory impairment. 
Patients who undergo gastrointestinal surgery will be at risk of nutritional depletion from 
inadequate nutritional intake; both preoperatively plus postoperatively, the stress of surgery and 
the subsequent increase in metabolism. More recently, ensuring adequate caloric intake has 
been a major focus of perioperative care and research has focused on the methods of giving 
nutritional support, their comparative clinical benefits and minimising such metabolic changes 
associated with surgical trauma. 
 
 
 METABOLIC CHANGES IN SURGERY PATIENTS 
                            The physiological stress of surgical trauma will cause a surge of sympathetic 
activity and an associated rise in catecholamine secretion. Such changes are transient. A more 
prolonged hypermetabolic state associated with the pronounced negative nitrogen balance then 
follows. Metabolic rate is typically increased by around 10% postoperatively. If adequate 
nutritional support is not provided at this stage it will leas to excessive skeletal muscle 
proteolysis occurs with further depression of metabolism. High energy expenditure is 
associated with a range of hormonal responses that occur due to surgical trauma. Cytokines, 
including Tumour Necrosis Factor (TNF) and interleukins (IL-1 and IL-6) are having an 
important role in determining longer-term metabolic changes. Such changes may not be 
clinically relevant unless postoperative sepsis or trauma following surgery but in conjunction 
with preoperative starvation often results in a high negative nitrogen balance. 
PHYSIOLOGICAL CHANGES IN SURGICAL PATIENTS 
                        It has been proved that intestinal permeability will be increased two to fourfold 
in the immediate postoperative period, although this will normalise within five days. In 
addition, nutritional depletion is associated with high intestinal permeability and a decrease in 
villous height. These findings have lead to an investigation of treatments aimed at maintaining 
an intact mucosal barrier. Increased intestinal permeability signifies a failure of the gut barrier 
function to exclude endogenous bacteria so also toxins. These have been proposed as causative 
agents in the systemic inflammatory response syndrome, septic shock and multi-organ failure. 
However, there has been a failure so far to prove a correlation between failure of gut barrier 
function and septic complications following major upper gastrointestinal failure. 
 CLINICAL BENEFITS OF NUTRITION IN SURGICAL PATIENTS 
                        Nutritional support leads to improved nutritional and metabolic status and 
clinical outcome in severely depleted patients. Studies about postoperative nutritional support 
have demonstrated reduced morbidity and reduced number of days of hospital stay. There is 
also evidence that artificial nutritional support in such malnourished patients is cost effective 
by reducing the costs associated to length of stay and morbidity with improved quality of life. 
It is important, however, to consider the most clinically correct and beneficial means of 
delivering nutritional support to surgical patients. Conventional treatment after bowel resection 
and anastomosis has typically entailed starvation with administration of intravenous fluids until 
passing of flatus, principally due to concerns over post-operative ileus. This was due to the 
assumption that oral feeding may not be tolerated in the presence of ileus and the integrity of 
the newly constructed anastomosis may be compromised. However, small intestinal motility 
resumes 6–8 hours after surgical trauma and moderate absorptive capacity exists even during 
the absence of normal peristalsis. It has since been shown that postoperative enteral feeding for 
patients undergoing gastrointestinal resection is safe and well tolerated even when begun 
within 12 hours of surgery. The commonest observed adverse effects were alimentary, such as 
abdominal cramps and bloating. 
                         An appropriate delivery method must be selected, depending on the anticipated 
duration of enteral feeding, aspiration risk plus gastrointestinal anatomy. No specific clinical or 
nutritional advantages have been shown in jejunostomy feeding and this route should be 
reserved for patients in whom naso-gastric and naso-jejunal feeding is not feasible or safe. 
Enteral feeding has been shown to result in many specific clinical benefits, including reducing 
the incidence of post-operative infectious sequelae and an improved wound healing response. 
Enteral nutrition may have other benefactory effects including altering antigen exposure and 
influencing oxygenation of the intestinal mucosa. More research is required in this area to 
elucidate whether enteral nutrition truly changes gut function or whether tolerance of enteral 
nutrition is predominantly indicative of  patients with healthy organ function. 
                         A large multi-centre clinical trial has showed no significant reduction in 
morbidity or mortality when Total Parenteral Nutrition (TPN) is administered perioperatively 
to a heterogeneous group of surgical patients. Stratification of these patients in this trial 
according to nutritional status showed that patients with mild malnutrition do not benefit from 
TPN but had more infectious complications. This led the authors to believe that perioperative 
TPN should be limited to severely malnourished patients in absence of other specific 
indications. Subsequent studies have principally focused on extremely malnourished patients 
with gastrointestinal malignancy. These patients have been showed to experience clinically 
significant reductions in both infectious and non-infectious complications while fed 
parenterally for a minimum of ten days pre-operatively. A recent meta-analysis of 27 different 
randomised controlled trials concluded that TPN has no statistically important effects overall 
on mortality or morbidity in surgical patients. The most recent studies analysed are of better 
methodological quality and showed fewer benefits than earlier studies. Studies that included 
only malnourished patients demonstrated a trend to a reduction in the complication rates. 
                          A standardised, validated definition about nutritional depletion would enable 
nutrition support to be targeted to such surgical patients most likely to derive significant 
clinical benefit in terms of improved postoperative result. This would also facilitate direct 
comparison of trial data for large meta-analyses taking "malnourished" patients to provide 
robust, evidence based guidelines about nutritional support of surgical patients. 
 
ANEMIA 
Anemia is the most common hematological pathology in the preoperative patient. Often, it is a 
sign of an underlying disease or condition which could affect the surgical outcome. 
Consequently, blood transfusions are commonly administered perioperatively to anemic 
patients. The risk of anemia in patients can be ensured from studies involving those who 
decline blood transfusions. The largest such study is a retrospective cohort study performed on 
1958 consecutive surgical patients who did not want transfusions based on religious reasons. 
The overall 30-day risk of mortality rose with decreasing preoperative hemoglobin 
concentrations, especially in those patients who had a hemoglobin level of less than 6 g/dL.6 
The risk of death was much higher, however, in patients with underlying cardiovascular disease 
with preoperative hemoglobin value of 10 g/dL or less. The subsequent study on the same 
population showed that none of the 99 patients whose postoperative hemoglobin concentrations 
between 7 and 8 g/dL died, whereas there was a steep rise in mortality in those patients with a 
hemoglobin concentration less that 5 to 6 g/dL. 
                            These results are consistent with the series of studies in which healthy 
subjects underwent acute isovolemic reduction to their hemoglobin level of 5 g/dL. Two of 
these studies found evidence of asymptomatic and reversible ST- segment alterations 
suggestive of myocardial ischemia in 5 of the 87 combined patients at hemoglobin levels 
between 5 to 7 g/dL. Another study evaluated eight healthy volunteers in isovolemic reduction 
and found self-assessed fatigue at a hemoglobin level of 7 g/dL, which then reduced further at 
hemoglobin levels of 6 g/dL and 5 g/dL. Minor and reversible cognitive alterations were seen 
in nine healthy subjects, including decreased reaction times at hemoglobin levels of less than 6 
g/dL and impaired immediate and delayed memory at hemoglobin concentrations less than 5 
g/dL. These studies show that even healthy subjects can exhibit clinical changes at hemoglobin 
levels between 5 and 7 g/dL. 
Normal Haemoglobin levels are: 
• Men: 13.8 to 18.0 g/dL (138 to 180 g/L, or 8.56 to 11.17 mmol/L) 
• Women: 12.1 to 15.1 g/dL (121 to 151 g/L, or 7.51 to 9.37 mmol/L) 
• Children: 11 to 16 g/dL (111 to 160 g/L, or 6.83 to 9.93 mmol/L) 
• Pregnant women: 11 to 14 g/dL (110 to 140 g/L, or 6.83 to 8.69 mmol/L) (9.5 to 15 
usual value during pregnancy) 
Dehydration or hyperhydration can greatly influence measured hemoglobin levels. Albumin 
can indicate hydration status. 
                           Elderly patients, however, can respond to and tolerate preoperative anemia 
differently than younger patients. In one study of twenty patients above the age of 65 and free 
from known cardiac disease, isovolemic anemia to a mean hemoglobin level of 8.8 g/dL was 
well tolerated. Another study examined patients who had known coronary artery disease and 
found that isovolemic anemia was well tolerated to hemoglobin level of 9.9 g/dL. In addition, 
the increase in cardiac index plus oxygen extraction during hemodilution was found to be 
independent of age. The results of this studies should be interpreted with caution as they 
involved small numbers of patients and very few were above the age of 80 years. A more 
recent study compared preoperative hematocrit levels in over 310,000 elderly veterans 
undergoing noncardiac surgery. In contrast to their two previous studies, even mild anemia was 
associated with an elevated risk of thirty-day morbidity and mortality. There was a monotonical 
rise in mortality and cardiac events while the hematocrit level was less than 39%. These results, 
however, may be unable to be generalized to elderly females. Moreover, it is unclear whether 
the anemia is causal or associated with the elevated morbidity and mortality, and whether this 
risk may be corrected with blood transfusion.  
                               There have been many observational trials documenting the effect of 
anemia and red blood cell transfusions on clinical outcomes of patients having surgery, those 
with acute coronary syndromes, and those admitted in intensive care units. With the exception 
of three studies, the risks of blood transfusion appeared to outweigh the benefits. Transfusion 
was associated with an elevated risk of death, infection, multiorgan dysfunction syndrome, and 
acute respiratory distress syndrome. But, this analysis has important limitations including that 
the analysis did not take into account the hemoglobin level before transfusion and very high 
likelihood of uncontrolled confounding. Patients requiring blood transfusions are more severely 
ill than the patients that do not require the transfusion and it is impossible to completely adjust 
for these differences between those patients who have received transfusions and those who 
have not. Therefore, the decision to transfuse blood in a preoperative patient must rest on the 
condition of the individual patient. 
                           In the case of iron deficiency anemia, the basic cause, such as blood loss, 
should be identified and treated. Therefore, a thorough gastrointestinal tract evaluation is often 
indicated. The supplementation of iron, however, must also be initiated. Iron is most easily 
given in the oral form, the least expensive of which was ferrous sulfate. Ferrous sulfate 
provides 65 mg of elemental iron per 325 mg tablet. It has been recommended that adults 
receive 150 to 200 mg of elemental iron per day in deficiency states. Peroral iron is more 
readily absorbed in an acidic gastric environment and, therefore, often given along with 
ascorbic acid and while avoiding antacids. Reticulocytosis is generally observed in seven to ten 
days, and the hemoglobin level should increase by 1 g/dL every two to three weeks. Those 
patients have failed oral iron therapy, or if iron loss exceeds capacity of oral iron absorption, 
intravenous iron therapy may be necessary. Common clinical scenarios where this occurs 
include patients with inflammatory bowel disease, intestinal malabsorption due to celiac 
disease, patients intolerant to oral iron therapy, or patients undergoing cancer chemoradiation. 
Of the intravenous iron preparations ferric gluconate and iron sucrose are usually thought to 
have the best safety profile. Recent studies and systematic reviews, however, suggesting that 
low-molecular-weight iron dextran may have a comparable toxicity profile with iron sucrose. 
Anemia due to vitamin B12 or folate deficiency can also be easily treated with 
supplementation. Folate deficiency must be treated with folic acid, 1 mg per day for up to four 
months, or until the patient’s anemia gets corrected. Vitamin B12 deficiency is usually treated 
with intramuscular cobalamin injections. The dose of cobalamin may vary depending on the 
severity of the anemia and symptoms, starting 1000 mcg daily for seven days, to 1000 mcg 
every one to four weeks. Studies have also suggested that oral cobalamin supplementation of 
1000-2000 mcg per day for four months, can be at least as effective as parenteral cobalamin, 
but this requires better patient compliance. Reticulocytosis may be expected in three to five 
days, and hemoglobin levels should increase within ten days. 
                             Patients with anemia of chronic disorder, chronic renal insufficiency, 
zidovudine-treated HIV-infected patients and other hematological disorders may benefit from 
use of erythropoietin prior to surgery. In many patients erythropoietin can raise the hemoglobin 
concentration enough to reduce the need for allogeneic patient blood transfusion after surgery. 
The target hemoglobin concentration must be no greater than 12 g/dL to avoid potential risks 
associated with erythropoietin (i.e., thromboembolism, severe cardiovascular events, and 
mortality), and all patients should received thromboembolism prevention.  
                          A special mention must be made about preoperative transfusions in patients 
with sickle cell disease, as the perioperative complication rate of this patient population can be 
as high as 67%. Surgical stress and trauma can elevate the rate of anemia and sickle cell 
formation, and red cell transfusions are often used to preserve oxygen-carrying ability and to 
dilute the sickle cells and thus transfusion-related complications are twice as likely.  
                            It is recommended to carefully evaluating each patient’s symptoms and signs 
and not basing the blood transfusion decision solely on a hemoglobin concentration. Those 
patients who are symptomatic because of their anemia should be transfused as needed. The 
optimal rate of red blood cell administration should be guided by the clinical situation. Active 
exsanguination may need transfusion rates as high as five to ten units of red cells over ten to 
fifteen minute, but, those patients at risk for volume overload should be transfused at one 
mL/kg/hour. Most patients can be transfused at one unit of red cells every one to two hours, 
and a hemoglobin level increase of 1 g/dL should be expected per unit of red cells transfused. 
After each red blood cell unit is transfused, a repeat hemoglobin level should be obtained, and 
the patient must be reevaluated. 
                          Anemia produces a unique set of challenges in the preoperative patient. An 
efficient evaluation of anemia relies on a detailed history as well as physical examination and a 
systematic approach to the diagnostic testing. The occurrence of anemia, as well as the use of 
perioperative blood transfusions, has significant ramifications on the surgical outcome. While 
the current evidence suggests a lower blood transfusion threshold may be appropriate in most 
preoperative patients, the decision to transfuse blood must be individualized to the patient and 
the clinical setting. 
 
SURGICAL TRAUMA AND THE STRESS RESPONSE 
                      The neuroendocrine, metabolic and inflammatory effects of injury are part of the 
overall ‘stress response’. This has been studied most widely in relation to surgery, because the 
catabolic changes that occur can be observed from a well-described starting point, but similar 
features occur in trauma, burns, severe infection and also in strenuous exercise. These result in 
substrate mobilization, muscle protein loss and sodium and fluid retention, with suppression of 
anabolic hormone secretion. There is activation of the autonomic nervous system and 
immunological and haematological changes. Generally, the extent of the metabolic response is 
proportional to the severity of the surgical trauma. These alterations have probably evolved to 
aid survival in a more primitive environment, by mobilizing substrates, reducing tissue 
damage, destroying infectious organisms and activating repair functions. Psychological and 
behavioural changes accompany the physiological events. The advantages of the stress 
response are not obvious in modern medicine, when physiological changes may be more easily 
corrected and it may even have a detrimental effect. Recently, research has focused on methods 
to modify the response associated with surgery in an attempt for improving patient outcome. 
 
Surgery evokes a series of hormonal and metabolic alterations commonly referred to as the 
stress response. There is increased secretion of pituitary hormones along with activation of the 
sympathetic nervous system. Increased catabolism mobilizes substrates for providing energy. 
Salt and water retention occur for maintaining fluid volume and cardiovascular homeostasis. 
Attempts have been made to modify the stress response post surgery with various anaesthetic 
techniques but these results are inconclusive. 
Initiation of response 
                              The hypothalamic–pituitary axis and the autonomic (sympathetic) nervous 
system are activated by afferent nerve input, both somatic and also autonomic, from the area of 
trauma or injury. There is a failure of the normal feedback loops of control of hormone 
secretion. For example, enhanced cortisol secretion fails to prevent further production of 
adrenocorticotrophic hormone (ACTH). In general, there is release of catabolic hormones like 
the catecholamines and pituitary hormones whereas anabolic hormones like insulin and 
testosterone are suppressed. Catecholamines are released from the adrenal medulla causing 
norepinephrine spills over from presynaptic nerve terminals responding to hypothalamic 
stimulation. Marked activation of the sympathetic nervous system resulting in tachycardia and 
hypertension. Hepatic, pancreatic and renal function are also modified. Renin is released from 
the kidneys leading to the conversion of angiotensin I to angiotensin II. The latter induces the 
secretion of aldosterone from the adrenal cortex, which in turn causes elevated sodium 
reabsorption from the distal convoluted tubule in the kidney. Glucagon released from endocrine 
pancreas stimulates the breakdown of glycogen in the liver and muscle leading to elevated 
glucose and lactate concentrations as well as mobilization of free fatty acids (FFAs) from 
available fat stores. However, the effects of insulin on fat and carbohydrate metabolism are 
much more significant. 
 
 
 
Pituitary gland 
               The anterior pituitary gland is regulated by hypothalamic releasing or inhibiting 
factors, which are secreted into the hypothalamic–hypophyseal portal system. The 
hypothalamus has direct neural control of the posterior pituitary gland. This secretion of the 
anterior pituitary hormones ACTH and growth hormone (GH) is stimulated by hypothalamic 
releasing factors, corticotrophin releasing factor (CRF) along with somatotrophin (or growth 
hormone releasing factor). The secretion of prolactin is within tonic inhibitory control via 
prolactin release inhibitory factor; perioperative elevated prolactin secretion occurs by release 
of inhibitory control. The secretion of various hormones, thyroid stimulating hormone (TSH), 
luteinizing hormone (LH) and follicle stimulating hormone (FSH) will not change 
significantly. Increased arginine vasopressin (antidiuretic hormone) released from the posterior 
pituitary, in addition to CRF, stimulates the production of the active amino acid pro-
opiomelanocortin in the anterior pituitary, which is the precursor molecule of ACTH, β-
endorphin and N-terminal precursor. ACTH stimulates cortisol production in a few minutes of 
the start of surgery. The production of ACTH is far in excess of what is required to produce a 
maximum adrenocortical response. The normal baseline value of cortisol is ∼400 nmol litre−1, 
that can increase to >1500 nmol litre−1 within 4–6 h of major surgery starting. The normal 
negative feedback mechanism fails and concentrations of ACTH and cortisol remains 
consistently increased. The magnitude and duration of the increase correlate well with the 
severity of an insult and the response is not abolished by the administration of steroids. The 
metabolic effects of cortisol are enhanced with skeletal muscle protein breakdown to supply 
gluconeogenic precursors and amino acids for protein synthesis in the liver, and stimulation of 
fat lysis. Glucose utilization is impaired, which is known as an ‘anti-insulin effect’ causing 
further hyperglycaemia. There are also mineralocorticoid effects with sodium and fluid 
retention and potassium loss. Cortisol also has well recognized anti-inflammatory effects 
regulated by a decrease in production of inflammatory mediators such as leukotrienes, 
cytokines as well as prostaglandins. 
                        Growth hormone has mixed catabolic as well as anabolic effects but increased 
secretion after surgery has only a minor physiological role but its diabetogenic effects are not 
thought to be important in the perioperative period. Glycogenolysis as well as lipolysis are 
promoted by GH while glucose uptake and utilization by tissues are inhibited. However, it may 
have a more important role in helping to prevent skeletal muscular protein breakdown and 
promote tissue repair. This action is achieved by the stimulation in the production of 
polypeptides in the liver, which are known as somatomedins also called insulin-like growth 
factors (IGFs). The main protein is somatomedin C (or IGF-1), that reduces protein catabolism. 
There has been considerable interest in the significant role of recombinant growth hormone or 
IGFs in improving wound healing, but evidence is  not conclusive. β-Endorphin is a peptide 
produced from the amino acid pro-opiomelanocortin and increased concentrations during 
surgery suggest anterior pituitary stimulation.  
Arginine vasopressin - The increased production of this hormone from the posterior pituitary 
has an anti-diuretic effect. It is also an important vasopressor and enhances haemostasis. ACTH 
release is enhanced by AVP. 
Insulin and glucagon - Insulin is a key anabolic hormone which is usually secreted in response 
to hyperglycaemia promoting glucose utilization and glycogen synthesis. Lipolysis is inhibited 
and muscle protein loss reduced. The failure of the body to secrete insulin in response to 
trauma is partly caused by the inhibition of the β-cells in the pancreas by the α2-adrenergic 
inhibitory effects of catecholamines. ‘Insulin resistance’ by target cells occurs later because of 
a defect in the insulin receptor/intracellular signalling pathway. Thus, the perioperative period 
is characterized by a state of functional insulin deficiency. In contrast to insulin, glucagon 
release promotes hepatic glycogenolysis and gluconeogenesis, but insulin effects predominate. 
Glucagon secretion increases briefly during surgery but it is not thought to make a major 
contribution to the hyperglycaemia. 
Other hormones 
                     Thyroxine (T4) and tri-iodothyronine (T3) are secreted by the thyroid, in response 
to TSH. T3 is five times more active than T4. They are highly bound in the circulation to 
albumin, thyroxine-binding pre-albumin and thyroid-binding globulin. They stimulate oxygen 
consumption in many organs, increase the metabolic rate and heat production. Circulating 
concentrations are inversely correlated with sympathetic activity and after surgery there is a 
reduction in thyroid hormone production, which returns to normal over a few days. The 
importance of the changes in gonadotrophin production and testosterone after surgery is 
uncertain. Testosterone concentrations are decreased for several days as are oestrogen values in 
females. 
                   The overall metabolic effect of the endocrine response is the mobilization of 
substrates from carbohydrate, lipid and protein stores. Hyperglycaemia is a major feature of the 
metabolic response to surgery and results from an increase in glucose production, at the same 
time as a reduction in glucose utilization. This is facilitated by catecholamines and cortisol, 
which promote glycogenolysis and gluconeogenesis. The hyperglycaemic response is enhanced 
by the iatrogenic effects of administration of glucose infusions and blood products. The usual 
mechanisms, which regulate glucose production and homeostasis, are ineffective because of 
initial failure of insulin secretion followed by insulin resistance. The size of the 
hyperglycaemic response reflects the severity of surgery or injury. Glucose concentrations >12 
mmol litre−1 impair wound healing and increase infection rates. There is also an increased risk 
of ischaemic damage to the nervous system and myocardium. 
                    Initially there is inhibition of protein anabolism, followed later, if the stress 
response is severe, by enhanced catabolism. Protein catabolism is stimulated by increased 
cortisol and cytokine concentrations. The amount of protein degradation is influenced by the 
type of surgery and also by the nutritional status of the patient. For example, after major 
abdominal surgery, up to 0.5 kg day−1 of lean body mass may be lost, which can cause 
significant muscle wasting and weight loss. Skeletal muscle protein is mainly affected but 
some visceral muscle protein may also be catabolized to release essential amino acids. The 
amino acids released form new proteins in the liver known as acute phase proteins, but albumin 
production is reduced interfering with the maintenance of the extracellular volume. Amino 
acids are also used for gluconeogenesis to maintain circulating blood glucose >3 mmol litre−1. 
The amount of protein loss can be assessed indirectly by measuring nitrogen excretion in the 
form of urea in the urine. Attempts to prevent protein loss after surgery, by providing 
nutritional support, enteral and parenteral, have proved disappointing. The availability of 
additional substrates has little effect in overcoming the inhibition of protein anabolism and 
preventing catabolism. 
                      Increased catecholamine, cortisol and glucagon secretion, in combination with 
insulin deficiency, promotes lipolysis and ketone body production. Triglycerides are 
metabolized to fatty acids and glycerol; the latter is a gluconeogenic substrate. High glucagon 
and low insulin concentrations also promote oxidation of FFAs to acyl CoA. Acyl CoA is 
converted in the liver to ketone bodies (β-hydroxybutyrate, acetoacetate and acetone), which 
are a useful, water-soluble fuel source. Heparinization (for example during cardiac surgery) 
activates lipoprotein lipase which stimulates lipolysis, but this is less of a problem with the new 
‘cleaner’ heparins. 
Salt and water metabolism - Arginine vasopressin secretion results in water retention, 
concentrated urine, and potassium loss and may continue for 3–5 days after surgery. Renin is 
secreted from the juxtaglomerular cells of the kidney secondary to sympathetic efferent 
activation. It converts angiotensin to angiotensin II, which in turn releases aldosterone from the 
adrenal cortex promoting sodium and water retention from the distal convoluted tubule. 
Cytokines - Cytokines are low molecular weight, heterogeneous glycoproteins that include 
interleukins (IL) 1–17, interferons, and tumour necrosis factor. They are synthesized by 
activated macrophages, fibroblasts, endothelial and glial cells in response to tissue injury from 
surgery or trauma. Although they exert most of their effects locally (paracrine), they can also 
act systemically (endocrine). Cytokines play an important role in mediating immunity and 
inflammation by acting on surface receptors of target cells. 
                        The most important cytokine associated with surgery is IL-6 and peak 
circulating values are found 12–24 h after surgery. The size of IL-6 response reflects the degree 
of tissue damage which has occurred. IL-6, and other cytokines, cause the acute phase response 
(Table 3), which includes the production of acute phase proteins such as fibrinogen, C reactive 
protein, complement proteins, α2-macroglobulin, amyloid A and ceruloplasmin. Other effects 
of cytokines include fever, granulocytosis, haemostasis, tissue damage limitation and 
promotion of healing. The immune system and neuroendocrine system are closely related. 
Cytokines may increase the release of cortisol although this has only been demonstrated in 
vitro and cytokine production is limited by cortisol in a negative feedback system. Thus, the 
cortisol response to surgery limits the severity of the inflammatory response. 
                             Refining surgical techniques may have some benefit in reducing the 
inflammatory responses. Cytokine release is reduced in less invasive surgery such as 
laparoscopic techniques leading to quicker recovery and discharge. Nutrition can also play a 
major part in preventing the adverse effects of the stress response. Enteral feeding, in particular 
immunonutrition (glutamine, arginine, omega-3 fatty acids) has been shown to improve 
recovery. There may also be a role for growth hormone and anabolic steroids in improving 
outcome. Insulin infusions, with and without glucose, may also reduce excess protein 
breakdown. Maintenance of normothermia is also beneficial in reducing the extent of the 
metabolic response to surgery. 
                           The hormonal and metabolic response to surgical and other physiological 
stresses is complex. It is important to reduce the deleterious effects of hypertension and 
tachycardia during surgery, particularly in patients with ischaemic heart disease. Modern 
anaesthetic practice strives to suppress sympathetic responses and maintain cardiovascular 
stability. However, there is no consistent method of suppressing the endocrine and metabolic 
changes and even when this is possible it is uncertain whether this benefits long-term 
outcomes. 
 
PROTEIN 
                       Proteins are essential nutrients for the human body. They are one of the building 
blocks of body tissue, and can also serve as a fuel source. As a fuel, proteins provide as much 
energy density as carbohydrates: 4 kcal (17 kJ) per gram; in contrast, lipids provide 9 kcal (37 
kJ) per gram. 
                   The amount of protein required in a person's diet is determined in large part by 
overall energy intake, the body's need for nitrogen and essential amino acids, body weight and 
composition, rate of growth in the individual, physical activity level, individual's energy and 
carbohydrate intake, as well as the presence of illness or injury. Physical activity and exertion 
as well as enhanced muscular mass increase the need for protein. Requirements are also greater 
during childhood for growth and development, during pregnancy or when breast-feeding in 
order to nourish a baby, or when the body needs to recover from malnutrition or trauma or after 
an operation. If not enough energy is taken in through diet, as in the process of starvation, the 
body will use protein from the muscle mass to meet its energy needs, leading to muscle wasting 
over time. If the individual does not consume adequate protein in nutrition, then muscle will 
also waste as more vital cellular processes (e.g. respiration enzymes, blood cells) recycle 
muscle protein for their own requirements. Protein Energy Malnutrition is predominantly seen 
in hospitals, is associated with disease, or is often found in the elderly. 
 
GASTROINTESTINAL ANASTOMOSIS 
Gastrointestinal anastomosis is a surgical procedure to establish communication between two 
formerly distant portions of the gastrointestininal tract. This procedure restores gastrointestinal 
continuity after removal of a pathologic condition affecting the bowel. 
Indications 
Indications for intestinal anastomosis can be broadly divided into two categories:  
1. Restoration of bowel continuity following resection of diseased bowel and  
2. Bypass of unresectable diseased bowel.  
Certain pediatric conditions may also require intestinal anastomosis. 
Resection of diseased bowel is performed in the following settings: 
• Bowel gangrene due to vascular compromise caused by mesenteric vascular disease, 
prolonged intestinal obstruction, intussusceptions, or volvulus 
• Malignancy 
• Benign conditions (eg, intestinal polyps, intussusception, roundworm infestation with 
intestinal obstruction ) 
• Infections (eg, tuberculosis complicated with stricture or perforation) 
• Traumatic perforations 
• Large perforations (traumatic) not amenable to primary closure 
• Radiation enteritis complicated with bleeding, stricture, or perforation 
• Inflammatory bowel disease, ulcerative colitis, or Crohn disease that is refractory to 
medical therapy or associated with complications (eg, bleeding, perforation, toxic megacolon, 
dysplasia/carcinoma) 
• Chronic constipation, idiopathic slow transit constipation, or Hirschsprung disease: 
Subtotal colectomy may be performed when the disease is refractory to medical therapy 
Bypass of unresectable diseased bowel is performed in following settings: 
• Locally advanced tumor causing luminal obstruction 
• Metastatic disease causing intestinal obstruction 
• Poor general condition or condition that prevents major resection 
Pediatric conditions for which intestinal anastomosis may be required include the following: 
• Congenital anomalies (eg, Meckel diverticulum, intestinal atresia, malrotation with 
volvulus leading to gangrene, meconium ileus, duplication cysts, Hirschsprung disease) 
• Inflammatory conditions (eg, necrotizing enteritis, enterocolitis, tuberculosis, enteric 
perforation) 
• Other conditions (eg, intussusception, angiodysplasia, polypoid disease, ascariasis) 
• As a part of other surgical procedures (eg, Kasai portoenterostomy, choledochal cyst, 
urinary diversions, pancreatic neoplasms) 
Contraindications 
Contraindications to intestinal anastomosis include conditions in which there is high risk of 
anastomotic leak, such as the following: 
• Severe sepsis 
• Poor nutritional status (eg, severe hypoalbuminemia) 
• Disseminated malignancy (multiple peritoneal and serosal deposits, ascites) 
• Viability of bowel in doubt 
• Fecal contamination or frank peritonitis 
• Unhealthy bowel condition - Precludes primary anastomosis 
Perioperative management 
Perioperative management includes the following: 
• Preoperative fluid resuscitation 
• Preoperative antibiotic prophylaxis 
• Placement of nasogastric tube and indwelling urinary catheter 
• Venous thromboembolism prophylaxis 
 
Operative techniques 
Adequate exposure and access, gentle handling of the bowel, adequate hemostasis, 
approximation of well-vascularized bowel, absence of tension at anastomosis, good surgical 
technique, and avoidance of fecal contamination are tenets of good intestinal anastomosis.  
The image below depicts a completed small-bowel anastomosis 
                            
Surgical techniques used in intestinal anastomosis include the following: 
• Incision and exposure 
• Bowel resection 
• Hand-sewn anastomosis (eg, bowel anastomosis, gastrojejunostomy, colorectal 
anastomosis, esophagogastric anastomosis) 
• Stapled anastomosis (eg, gastrojejunostomy, small bowel anastomosis, colorectal 
anastomosis, cervical esophagogastric anastomosis) 
 
Postoperative complications 
Important complications following intestinal anastomosis include the following: 
• Anastomotic leak 
• Bleeding 
• Wound infection 
• Anastomotic stricture 
• Prolonged functional ileus, especially in children 
• Intestinal anastomosis is a surgical procedure to establish communication between two 
formerly distant portions of the intestine. This procedure restores intestinal continuity after 
removal of a pathologic condition affecting the bowel. Intestinal anastomosis is one of the most 
commonly performed surgical procedures, especially in the emergency setting, and is also 
commonly performed in the elective setting when resections are carried out for benign or 
malignant lesions of the gastrointestinal tract. 
• A disastrous complication of intestinal anastomosis is anastomotic leak resulting in 
peritonitis, which is associated with high morbidity and mortality. Proper surgical technique 
and adherence to fundamental principles is imperative to ensure successful outcome after 
intestinal anastomosis. 
• Intestinal anastomosis can be performed by means of a hand-sewn technique that uses 
absorbable or nonabsorbable sutures or by means of stapling. The former is the more 
commonly used option because of the availability and affordability of suture materials and the 
wide familiarity with the procedure. The increased availability of stapling devices for intestinal 
anastomosis has provided an alternative option to perform a rapid anastomosis. Higher cost, 
limited availability, and less familiarity are the main drawbacks of these devices. Less common 
techniques for intestinal anastomosis use compression devices (biofragmentable anastomotic 
rings), glue (tissue or synthetic), and laser welding. 
 
Procedural planning 
Although an inverting anastomosis has been found to be better than an everting anastomosis, 
there is no difference in complication rates between single-layer and double-layer techniques or 
between continuous and interrupted anastomosis. 
Stapled anastomotic technique has virtually replaced hand-sewn technique for low colorectal 
anastomosis, and its use in other areas has also increased. Although stapled anastomosis has 
not yet been proved superior to hand-sewn anastomosis, it has definitely reduced the operating 
time and facilitated the ease of doing the procedure, especially in low colorectal anastomosis. 
Although restoration of bowel continuity is generally preferred, a decision has to be made 
judiciously in emergency settings. A staged procedure may be preferred for restoration of 
bowel continuity if the general condition of the patient is not good enough to avoid the 
complications associated with anastomotic leak. 
 
Complication prevention 
An important component of preventing complications related to intestinal anastomosis is to 
complete preoperative optimization of patients' medical status, including correction of 
malnutrition with nutritional support and treatment of associated systemic illness. However, 
this is generally possible only in elective resections, not in emergency situations. 
The following can also help prevent complications: 
• Adequate exposure and access 
• Gentle handling of the bowel 
• Adequate hemostasis 
• Approximation of well-vascularized bowel 
• Absence of tension at anastomosis 
• Good surgical technique 
• Avoidance of fecal contamination 
It is very important to prevent hypothermia and hypovolemia during surgery, especially in 
children. Thermal mattresses should be used for thermoregulation, especially for neonates. 
Fluid loss should be minimized and losses should be adequately replaced. Adequate blood 
should be arranged. 
 
Preprocedural Planning 
Preoperative fluid resuscitation to optimize hydration status is imperative because patients who 
present in emergency settings are frequently dehydrated. 
Preoperative antibiotic prophylaxis is a must to prevent infective complications in emergent 
settings, as well as some elective settings when associated with a major surgical procedure. 
A nasogastric tube and indwelling urinary catheter should be inserted to decompress the 
stomach and the urinary bladder, respectively. Decompression of the stomach reduces the risk 
of aspiration of gastric contents during induction of anesthesia. 
Traditionally, mechanical bowel preparation is given before elective colorectal procedures to 
prevent anastomotic complications. However, there is now evidence in the literature to suggest 
that mechanical bowel preparation does not have any beneficial effect on the complication rate; 
in fact, it might have a detrimental effect on healing by causing immune changes in colonic 
mucosa that interfere with the healing process. 
Venous thromboembolism prophylaxis is a must to prevent deep vein thrombosis of lower 
limbs and possibly mesenteric venous thrombosis in high-risk patients (thrombophilic state). 
 
 
 
 
 
Equipment 
Intestinal anastomosis is performed in an operating room, which should be equipped with the 
following: 
• Anesthetic equipment, overhead lights, and an operating table that is preferably power-
controlled to ensure smooth and accurate positioning for various surgical procedures, 
electrodiathermy, and suctioning systems 
• Appropriate laparoscopic instruments and monitors (preferably high-definition) if 
laparoscopic resection and anastomosis is contemplated 
• Double-lumen endotracheal tube with single-lung ventilation is required for 
thoracotomy/thoracoscopic esophagectomy and anastomosis 
• All types of suture materials (absorbable/nonabsorbable, monofilament/multifilament) 
used for intestinal anastomosis 
• Stapling devices commonly used for intestinal anastomosis, such as a transverse 
anastomosis (TA) stapler, gastrointestinal anastomosis (GIA) stapler, and circular end-to-end 
anastomosis (EEA) stapler (if stapled intestinal anastomosis is planned) 
 
Anesthesia 
Intestinal anastomosis is performed with the patient under general anesthesia. A double-lumen 
endotracheal tube with single-lung ventilation is required for thoracotomy/thoracoscopic 
esophagectomy and anastomosis. Patients who are anesthetized for emergency surgery (eg, for 
intestinal obstruction or gangrene gut) are at greater risk for aspiration of gastric contents. The 
risk of aspiration can be reduced by emptying the stomach before induction and by using rapid-
sequence induction technique. 
Positioning 
Patient positioning depends upon the type of surgical procedure. Most abdominal operations 
are performed in the supine position with arms abducted at right angles to the body or 
sometimes by the side of the body. Pelvic procedures are performed with the patient in the 
lithotomy position. 
Care should be taken to avoid excessive flexion or abduction. Adequate padding of pressure 
points should be ensured to avoid neurologic damage and pressure ulcerations. Esophageal 
procedures (requiring thoracotomy) are performed with the patient in a lateral or semiprone 
position. Patient positioning also must be changed during the course of operation to facilitate 
performance of the surgical procedure. 
 
Approach Considerations 
Preoperative nasogastric aspiration is usually required. Similarly, urinary catheterization is 
necessary in critically ill patients, during emergency resections, or when infraumbilical incision 
is used to protect the urinary bladder from injury during laparotomy. 
An exploratory laparotomy may be performed. If the disorder is diagnosed preoperatively, the 
pathology can be identified and the part of the intestine to be resected can be isolated and 
excised. Continuity is restored by performing the anastomosis. 
Sometimes, the resection and anastomosis of the bowel could be components of another major 
surgical procedure, such as a Whipple procedure, gastrectomy, urinary diversions, or resection 
of a retroperitoneal tumor. 
 
 
Incision and Exposure 
Adequate access is the key to ensuring successful intestinal anastomosis. A midline incision is 
commonly used for the majority of abdominal operations. The use of self-retaining retractors 
ensures adequate exposure. Exposure in pelvic operations can be improved by changing the 
position of the patient (Trendelenburg position) so as to displace small-bowel loops away from 
the pelvis. Packing the small bowel with wet sponges also improves exposure in pelvic 
procedures. A supraumbilical transverse incision is frequently used in younger children. 
 
Bowel Resection 
The portion of bowel to be resected should be adequately mobilized. Mobilization is rarely a 
problem with the small bowel, which can be easily brought to the surface. However, the large 
bowel (especially the retroperitoneal segments) should be adequately mobilized by dividing the 
lateral peritoneal reflection. Bowel mobilization, in addition to facilitating resection, ensures 
tension-free anastomosis. 
After mobilization of the bowel, the next step is division of the mesentery. Principles to be 
followed in division of the mesentery include the following: 
• Transillumination to identify mesenteric blood vessels 
• Isolation of vessels by dividing surrounding fat 
• Division between clamps 
• Ligation with suitable sutures to prevent knot slippage 
On-needle transfixation of large vascular pedicles with nonabsorbable sutures is a safer 
method. Bleeding or hematoma formation within the leaves of mesentery should be avoided, 
and preservation of vascular arcade to the bowel ends should be ensured so as to have 
satisfactory vascularity of the anastomosed bowel. Alternatively, the mesentery can be divided 
with an ultrasonic scalpel. 
The next step is division of the bowel. This is done by applying a noncrushing clamp on the 
bowel end used for anastomosis and applying crushing clamps on the bowel to be resected so 
that the intraluminal contents of the resected bowel do not contaminate the peritoneal cavity. 
Clamps are applied from the antimesenteric end, and care should be taken to avoid crushing of 
the mesentery. 
The bowel is divided with a knife close to the crushing clamp so as to preserve adequate bowel 
length distal to a noncrushing clamp for anastomosis. The direction of division is oblique to 
ensure an adequate lumen and to maintain a longer length of the mesenteric end as compared to 
the antimesenteric end. The specimen is removed with clamps in situ. 
Care should be taken to avoid spillage of enteric contents during bowel division. Alternatively, 
bowel division can also done with a linear cutting (gastrointestinal anastomosis [GIA]) stapler, 
which divides and seals two cut ends simultaneously, thereby preventing fecal contamination. 
 
Hand-Sewn Small bowel Anastomosis 
This section describes a double-layer sutured end-to-end small-bowel enteroenterostomy. Two 
cut ends of the bowel are brought in close apposition. Stay sutures of 3-0 silk are placed 
between the serosa of the proximal and distal ends of the bowel approximately 5 mm from the 
cut end. 
Interrupted seromuscular sutures (Lembert stitches) of 3-0 silk are placed between these stay 
sutures with an approximately 3-mm gap between each two sutures. Lembert stitches should 
incorporate only the seromuscular layer; care must be taken not to incorporate the full thickness 
of the bowel wall. Sutures are tied sequentially, with care taken not to apply excessive tension 
so as to minimize the risk of cut-through of the seromuscular layer. This forms the posterior 
outer layer. 
Next, a Connell stitch is made in both ends. The Connell stitch is achieved by passing the 
suture from the outside in, then inside out, on one end. The same step is repeated on the other 
end in the form of a continuous U-shape. The suture is tied so that the knot is outside. The 
posterior inner layer is completed by taking interrupted full-thickness stitches of 3-0 
polyglactin, starting from the near end. The sutures are tied sequentially so that the knot lies 
inside the lumen. 
The needle must be pulled through each edge separately. Trying to include both edges in one 
pass of the needle can prevent the surgeon from taking a full-thickness bite on both edges. It is 
necessary to include the submucosa carefully because this is the strongest layer of the bowel 
wall and gives strength to the anastomosis. 
The anterior inner layer is completed in a similar fashion, starting from the far end. The pouting 
of mucosa is prevented by taking a small amount of mucosa and a large part of the 
seromuscular layer, which results in inversion of the mucosa. 
The anterior outer seromuscular layer is completed by taking interrupted Lembert stitches. 
Narrowing of the lumen by including too much of the bowel into this layer should be avoided. 
Patency of the lumen can be confirmed by palpation across the anastomosis with the tips of the 
thumb and the index finger. The mesenteric defect is closed with interrupted stitches of 3-0 
silk. Care should be taken to avoid injuring mesenteric vessels so as to prevent ischemia of the 
anastomotic site. 
 
Gastrojejunostomy 
This section describes the technique of gastrojejunostomy following distal gastrectomy. The 
first step is to bring up the jejunal loop in an antecolic position. 
Interrupted Lembert seromuscular stitches of 3-0 silk are placed between the antimesenteric 
end of the jejunum and the posterior gastric wall. This forms the posterior outer layer. After 
application of a noncrushing intestinal clamp across the jejunal loop, an incision is made in the 
jejunum with a knife approximately 5 mm lateral to the seromuscular stitches. 
The size of the jejunal opening should be slightly smaller than the gastric opening because the 
small bowel tends to stretch while taking sutures. Two Babcock clamps are placed (one on each 
anterior wall) to expose the posterior gastric and jejunal walls.  
The posterior inner layer is started by making a Connell stitch at the near end with 3-0 
polyglactin. The suture is tied so that the knot lies outside the lumen, and the free end of the 
thread is kept long and held with a hemostat. After the lumen is entered from the outside in 
with the needle end of the suture, full-thickness continuous interlocking stitches are taken 
through both edges. The needle must be pulled through each edge separately to ensure a full-
thickness bite on both edges. This forms the posterior inner layer. 
Once the far end is reached, a Connell stitch is made, and the anterior inner layer is completed 
by taking continuous interlocking through-and-through stitches. A loop-on-mucosa suture 
technique is followed, in which the suture is taken from the inside out of the jejunal wall and 
outside in through the stomach wall, with the pull on the suture being within the lumen. This 
ensures good inversion of the mucosa (see the image below). 
Good inversion of the mucosa is also ensured by taking a small amount of mucosa and a large 
part of the seromuscular layer. Once half of the anterior inner layer is completed, clamps are 
released to ensure the absence of bleeding in the posterior layer. If bleeding points are 
identified, they are controlled by taking interrupted full-thickness stitches through both edges. 
The anterior inner layer is completed by tying the free end of the thread on the near end. The 
double-layer anastomosis is completed with an anterior seromuscular layer of interrupted 3-0 
silk sutures. 
 
Colorectal anastomosis 
Reconstruction after an anterior resection can be performed in either an end-to-end or a side-to-
end fashion. A side-to-end technique (Baker anastomosis) is preferred when there is a size 
discrepancy between two bowel ends. This section describes the technique of end-to-end hand-
sewn colorectal anastomosis following anterior resection. 
Two bowel ends with right-angle clamps in situ are brought close by applying lateral 
seromuscular traction sutures of 3-0 silk. The anastomosis is performed in a single layer with 
3-0 silk. Posterior interrupted full-thickness sutures are taken from the distal rectum to the 
proximal sigmoid colon. Sutures are not tied but are held long with a hemostat. This ensures 
accurate placement of full-thickness sutures. 
After completion of the posterior layer, sutures are tied in order, starting from one corner. 
While one suture is being tied, the next suture should be held taut by an assistant to ensure that 
there is no abnormal gap between the two sutures. Next, full-thickness interrupted anterior-
layer sutures are taken, following principles similar to those adopted for the posterior layer. 
Sutures are then tied to complete the anastomosis. The integrity of the anastomosis can be 
checked by filling the pelvis with saline and instilling air through the anus to look for any air 
bubbles. Transanal anastomosis has also been described after total mesorectal excision.[9, 10] 
  
Esophagogastric anastomosis 
The characteristic feature of the esophageal anatomy is the unusually fatty submucosa, which 
allows greater mobility of the overlying mucosa. In performing an esophageal anastomosis, 
care should be taken to ensure that every suture transfixes the mucosal edge, which can retract 
more than 1 cm from the cut esophageal margin. The esophagus also lacks a serosal layer, so 
that the soft and often tenuous muscle holds sutures poorly. This section describes the 
technique of two-layer end-to-side esophagogastric anastomosis using 3-0 silk. 
The outer posterior layer uses interrupted stitches between the muscular layer of the esophagus 
and the seromuscular layer of the stomach. Initially, sutures are placed without being tied. 
During tying, care should be taken to draw the stomach towards the esophagus because the 
muscular layer of the esophagus holds sutures poorly. Corner ties are left long and held with a 
hemostat. 
The posterior inner layer uses interrupted stitches left long without tying. The mucosa should 
be identified and included in each stitch to achieve mucosal apposition and avoid anastomotic 
leak. Sutures are then tied sequentially so that the knot lies inside the lumen. At this stage, the 
nasogastric tube is passed from the esophagus into the stomach and fixed by the anesthetist to 
the patient’s nose. 
The anterior inner layer is completed in a similar fashion, with care taken to include mucosa. 
The sutures are tied so that the knot lies outside the lumen. 
Anastomosis is completed by taking the anterior outer layer of interrupted stitches between the 
muscular layer of the esophagus and the seromuscular layer of the stomach. 
A single-layer esophagogastric anastomosis also can be fashioned with interrupted silk sutures. 
Before the anastomosis is performed, the stomach can be hitched to the prevertebral fascia with 
interrupted silk sutures so that it does not slide down with peristalsis. 
 
Stapled Small bowel Anastomosis 
A stapled small-bowel anastomosis can be performed in either an end-to-end (anatomic or 
functional) or a side-to-side fashion. True anatomic end-to-end small-bowel anastomosis is 
performed with a noncutting linear stapler. An important prerequisite for this type of 
anastomosis is that there should not be any disparity in size between the two bowel ends. 
The first step is to triangulate the bowel ends by placing three traction sutures. The linear 
stapler is placed between two of the sutures and fired. The same process is repeated twice on 
the other two sides of the triangle by rotating the bowel. Any excess tissue remaining after the 
firing of the stapler is removed. This technique results in an everting anastomosis. Potential 
drawbacks of this technique are the possible anastomotic site stricture and ischemic damage 
secondary to an injury of mesenteric blood vessels when staples are applied close to the 
mesenteric end. 
However, stapled small-bowel anastomosis is commonly performed in a functional end-to-end 
fashion by using a linear cutting stapler. In this technique, two cut ends of the bowel are placed 
side to side. The two forks of the stapling device are placed through open bowel ends or an 
enterotomy (made in the antimesenteric border if the bowel ends are stapled). Care should be 
taken to avoid inclusion of the mesentery between branches of the stapler. The stapler is fired 
to create lumen between two bowel segments by dividing the two bowel walls. The bowel ends 
or enterotomy can be closed by applying a linear stapler or using a hand-sewn technique. 
Bleeding from stapled edges is better controlled by taking underrunning sutures. Care should 
be taken to avoid application of cautery to the stapled edge; doing so can result in transmission 
of electric current to the rest of the bowel, resulting in thermal damage. 
 
Gastrojejunostomy 
This section describes the technique of stapled gastrojejunostomy following subtotal 
gastrectomy. Resection of the stomach is carried out with a linear cutter so that the cut end is 
excised and simultaneously stapled. 
After completion of the gastrectomy, the jejunal loop is brought up in an antecolic or retrocolic 
fashion. Seromuscular interrupted stay sutures of 3-0 silk are placed between the posterior 
gastric wall close to the greater curvature and the jejunal wall to bring them in apposition. A 
small gastrotomy and enterotomy are made to facilitate the passage of a 55-mm linear cutting 
(GIA) stapler. 
The two limbs of the GIA stapler are placed simultaneously into the stomach, with the cartridge 
fork of the linear cutter inside the stomach. Care should be taken not to include part of the 
small-bowel mesentery. The stapler is fired so that the common wall between the stomach and 
the jejunum is divided and the gastrojejunostomy created. 
The nasogastric tube can be either placed in the stomach or advanced into the efferent jejunal 
loop if early enteral feeding is planned. The enterotomy and gastrotomy can be closed with an 
appropriately sized linear stapler or in two layers, with the inner continuous layer using 3-0 
polyglactin and the outer interrupted layer using 3-0 silk. 
 
 
Colorectal anastomosis 
A stapled colorectal anastomosis following anterior or lower anterior resection for carcinoma 
of the rectum can be performed in either an end-to-end or an end-to-side fashion. This section 
describes the technique of an end-to-end double-stapled colorectal anastomosis. 
After mobilization of the splenic flexure, proximal division of colon is performed at the 
junction of the sigmoid and descending colon. Bowel division can be performed by using a 55-
mm linear transverse anastomosis (TA) stapler or cutting with a knife after applying a bowel 
clamp. 
After complete mobilization of the rectum, a right-angle clamp is applied distal to the tumor, 
and the distal rectum is divided with a linear stapler (30-mm or 45-mm contour device or 
roticulator) applied distal to the right-angle clamp. An adequate distal mural margin (2 cm) is 
necessary to prevent recurrence. The distal rectal stump can be washed with saline or dilute 
povidone-iodine to destroy exfoliated tumor cells shed in the distal rectum before a clamp or 
stapler is applied. 
After division of the distal rectum, the bowel ends are prepared for a double-stapled 
anastomosis using a circular stapler (31-mm or 33-mm end-to-end anastomosis [EEA] stapler). 
The proximal bowel is prepared by applying full-thickness purse-string stitches of 3-0 silk or 
polypropylene. The anvil head is placed in the proximal colon, and the purse-string suture is 
tied above the tying notch. 
After gentle dilatation of the anus, the shaft of the circular EEA stapler is advanced through the 
anal canal under the guidance of the abdominal surgeon and placed close to the staple line with 
the trocar fully retracted inside. The trocar is then fully extended so as to pierce the tissue and 
advance through the rectal wall, either anterior or posterior to the staple line. The detachable 
head assembly is then reattached by sliding the anvil shaft over the trocar and pushing until the 
detachable head assembly snaps with the trocar into its fully seated position. 
The ends of the circular stapler are closed, with care taken to confirm that there is no twist in 
the mesentery of the proximal colon. The stapler is tightened completely, fired, and then gently 
removed by rotating it counterclockwise for half a turn before removal. The presence of two 
intact donuts should be confirmed. 
The integrity of the anastomosis should be checked by filling the pelvis with saline, instilling 
air in the distal rectum, and looking for air bubbles. If donuts are not complete, additional 
sutures should be made. In some cases, proximal diversion with proximal colostomy or 
ileostomy may be considered. 
 
Cervical esophagogastric anastomosis 
This section describes the technique of stapled cervical esophagogastric anastomosis 
popularized by Orringer. After removal of the tumor-bearing segment of the esophagus and 
division of the proximal esophagus, the gastric tube is brought into the neck. A 1.5- to 2-cm-
long anterior vertical gastrotomy is made for passage of stapler. 
The site for the gastrotomy is selected by approximating the divided end of the esophagus 
against the anterior gastric wall. It should be low enough to facilitate subsequent placement of a 
3-cm-long stapler cartridge. 
The esophagus is aligned to the stomach by placing two stay sutures. The first suture is the full-
thickness stitch through the anterior corner of the esophagus. The second is the full-thickness 
stitch through the upper end of the gastrotomy (inside out) to the posterior corner of the divided 
esophagus (outside in). A GIA stapler (30 mm) is inserted simultaneously into the stomach and 
esophagus while downward traction on the sutures is maintained, with the thicker staple-
bearing portion of cartridge inside the esophagus. 
Two stay sutures are placed between the anterior gastric wall and the adjacent esophagus on 
either side of the stapler to take tension off the anastomosis. The stapler is fired so that the 
common wall formed by the posterior esophageal wall and anterior gastric wall is divided, 
creating a large esophagogastric anastomosis. 
A 16-French nasogastric tube is inserted by the anesthetist and advanced across the 
anastomosis into the intrathoracic stomach. 
The esophagotomy and gastrotomy are closed with sutures in two layers (an inner continuous 
layer using 3-0 or 4-0 polyglactin and an outer interrupted layer using 3-0 silk). 
 
Complications 
Important complications following intestinal anastomosis include the following: 
• Anastomotic leak 
• Bleeding 
• Wound infection 
• Anastomotic stricture 
• Prolonged functional ileus, especially in children 
 
Anastomotic leak 
Anastomotic leak is the most feared early complication of intestinal anastomosis. The healing 
of an intestinal anastomosis is broadly divided into three phases, as follows: 
• Inflammatory phase 
• Fibroplasia phase 
• Remodeling phase 
During the inflammatory phase, the integrity of the anastomosis is dependent on mechanical 
strength provided by sutures. The inflammatory phase is followed by the fibroplasia phase 
around postoperative days 5-7; this phase is characterized by a switch from collagen 
degradation to collagen deposition, which gives strength to the anastomosis. Any systemic or 
local factor that causes delay in the transition from the inflammatory phase to the fibroplasia 
phase can result in poor healing and anastomotic leak. 
 
       Systemic conditions that increase the risk of anastomotic leak are anemia, diabetes 
mellitus, malnutrition with hypoalbuminemia, vitamin deficiencies, and steroid therapy. Local 
factors such as the presence of irradiated bowel, anastomosis involving disease-affected bowel, 
and inadequate blood flow are associated with poor healing and anastomotic leak. 
                Anastomotic leak presenting on postoperative day 1 or 2 is invariably due to 
technical reasons. Anastomotic leak secondary to interference in the normal healing mechanism 
usually presents around the end of postoperative week 1. Anastomotic leak can present either 
as frank peritonitis when the leak is uncontrolled or as localized intra-abdominal 
collection/abscess if the leak is controlled. 
An uncontrolled leak with diffuse peritonitis is associated with high morbidity and mortality 
and necessitates reexploration. During repeat laparotomy, a thorough lavage of the peritoneal 
cavity should be carried out. In most circumstances, it is better to dismantle the anastomosis 
and bring out the bowel loops as a stoma. A controlled leak presenting with a localized intra-
abdominal abscess can be managed conservatively with percutaneous drainage of the abscess 
under imaging guidance and antibiotics. 
 
Bleeding 
Bleeding-related complications after intestinal anastomosis are common in patients with sepsis 
and deranged coagulopathy. Bleeding may manifest in the immediate postoperative period as 
hemorrhagic aspirate from the nasogastric tube, hematemesis, melena, or bleeding from an 
intra-abdominal drain. Patients with bleeding should be aggressively managed with correction 
of coagulopathy (if present) and blood transfusion. If the bleeding results in hemodynamic 
instability with a significant decrease in hemoglobin, urgent reexploration should be 
performed. Intraoperative anastomotic site bleeding is characterized by blood in the intestinal 
lumen distal to the anastomosis. In such circumstances, the anterior layer of the sutures is 
opened and both layers are examined for evidence of any bleeding. 
Once the bleeding site is identified, it can be controlled with hemostatic sutures. The decision 
to reanastomose or to convert into a stoma depends on the general condition of the patient. 
Conversion to a stoma is preferred in patients who are hemodynamically unstable. 
 
Wound infection 
Wound infection occurs when there is uncontrolled spillage of intestinal contents during 
anastomosis. It is managed by removing a few skin sutures and ensuring proper drainage of 
pus. Superficial surgical site infection does not require treatment with systemic antibiotics. 
 
 
Anastomotic stricture 
Anastomotic stricture is a late complication of intestinal anastomosis. The risk of anastomotic 
stricture is marginally increased after end-to-end anastomosis, especially when the anastomosis 
is performed with a stapled technique. The most important risk factor for anastomotic stricture 
is a controlled anastomotic leak managed conservatively. This scenario is more common after 
cervical esophageal and colorectal anastomotic leak. Anastomotic strictures occurring in these 
areas can be conservatively managed with endoscopic or colonoscopic dilatation. If this fails, 
surgical revision might be required. 
 
Controversies 
Type of suture material: The ideal suture material is one that is easy to handle, ties without 
fraying, is easy to sterilize, elicits little or no inflammation, and maintains the strength of the 
anastomosis during the lag phase of healing. None of the currently available suture materials 
fulfills all of these criteria. 
Absorbable suture materials that are commonly used for intestinal anastomosis include the 
following: 
• Polyglactin 
• Polyglycolic acid 
• Chromic catgut 
The first two elicit less inflammation than catgut does. 
Silk is the most commonly used nonabsorbable suture, though it initiates an intense 
inflammatory reaction. Newer synthetic nonabsorbable sutures (eg, polypropylene) elicit less 
inflammatory reaction. 
In general, in two-layer anastomoses, absorbable sutures of polyglycolic acid or polyglactin are 
used, with an outer seromuscular stitch of silk. In one-layer anastomoses, a nonabsorbable 
suture such as silk is preferred. 
Single-layer vs double-layer anastomosis 
Intestinal anastomosis is traditionally performed in two layers. The shortcoming of the two-
layer technique is that it is somewhat tedious and time-consuming to perform. Potential 
advantages of the single-layer technique are that it takes less time to perform and that it costs 
less, though safety may be a concern. However, randomized trials and meta-analyses 
comparing the two techniques of intestinal anastomosis did not find increases in the rate of 
anastomotic leak, the incidence of perioperative complications, mortality, or the length of 
hospital stay with the single-layer technique. 
 
Continuous vs interrupted sutures 
An intestinal anastomosis can be fashioned by using either simple (continuous) or interrupted 
sutures. A continuous suture is less time-consuming to place, and the suture line is more 
watertight with better hemostasis. However, the entire suture line is based on a single stitch. 
Animal studies have shown that anastomotic blood flow and perianastomotic oxygen tension is 
low after a continuous suture, resulting in impaired healing and increased complication rates. 
However, prospective randomized trials have failed to show any difference in complication 
rates between the two techniques. 
 
 
 
Hand-sewn vs stapled anastomosis 
The introduction of reliable disposable instruments has led to an increase in the use of stapling 
devices for intestinal anastomosis.  
Important advantages of the stapled technique are the shorter operating time and the greater 
ease of performing the procedure, especially in low pelvic anastomoses. 
 
Inverting vs everting anastomosis 
Currently, inverted anastomosis is the most widely used technique worldwide. 
 
The outcome of patients who undergo gastrointestinal surgery varies greatly. Factors such as 
the patient’s age and comorbidities, the complexity of the surgical procedure and the 
management of postoperative recovery influence the outcome. Modern perioperative 
management has been improved in numerous ways over the last decade and nowadays is 
regarded as a highly multidisciplinary task. Because an ageing population is leading to more 
and more patients with multiple comorbidities being referred to surgery and because surgical 
procedures and multimodal treatment modalities are becoming increasingly complex, close 
cooperation between surgeons and anaesthesiologists (i.e. joint risk assessment) is critical for 
improving outcome after major gastrointestinal surgery. Internists are also frequently involved 
to optimise the patient’s physical condition or medication. 
Preoperative management 
Medical history and clinical assessment 
A detailed medical history and a thorough clinical assessment of the patient’s physical and 
psychological condition are of utmost importance, as it may help to identify patient risk factors 
for imminent morbidity or mortality (e.g. an unappreciated reduction of physical fitness, 
specific medications or newly developed medical illness). Ideally, the medical history is taken, 
and the assessment performed before the patient’s admission to the hospital so that certain 
medical conditions can be optimised (e.g. stabilisation of chronic heart failure, poorly 
controlled diabetes mellitus or arterial hypertension). However, when surgery is required for a 
gastrointestinal malignancy, a thorough pre-admission assessment may not be wise because it 
could substantially delay surgery. 
 
Routine diagnostic tests 
Close interaction between surgeons and anaesthesiologists is critical for improving patient 
outcome after major gastrointestinal surgery, and risk assessment should always be joint. There 
are routine test results that should be available before the patient is referred to anaesthesiology 
consultation. 
 
Laboratory tests 
Preoperative laboratory testing should be performed for all patients prior to gastrointestinal 
surgery. At minimum, the testing should consist of: 
• Standard blood count 
• International normalised ratio 
• Activated partial thromboplastin time (aPTT) 
• Concentrations of sodium, potassium, creatinine and glucose 
Certain procedures or clinical conditions may require additional assessments. Occasionally, a 
laboratory test may be required on the day of surgery (e.g. serum potassium levels after 
extensive mechanical bowel preparation (MBP) or glucose levels for patients with severe 
diabetes mellitus). Recent data have indicated that an elevated preoperative level of brain 
natriuretic peptide is associated with increased cardiac morbidity after major surgery, but it 
remains to be seen whether this level will be routinely determined for patients with cardiac risk 
factors. 
 
Electrocardiography 
Preoperative 12-channel electrocardiography (ECG) allows for screening of as-yet undetected 
cardiac disorders. It also serves as a control should perioperative cardiac complications occur. 
ECG should be performed for patients who: 
• Are >40 years old 
• Have relevant cardiac disorders (e.g. coronary artery disease, heart insufficiency, heart 
rhythm disturbances or valve disorders) 
• Have a pacemaker (PM) or implanted cardioverter/defibrillator (ICD) 
• Have newly developed pulmonary or cardiac symptoms 
• Are receiving preoperative chemotherapy or chemoradiotherapy 
Although it is not routine practice, many clinicians recommend that for patients with coronary 
artery disease who underwent high-risk surgery, an additional ECG should be obtained 
immediately after surgery as well as on days 1 and 2 postoperatively. 
 
Chest radiography: The sensitivity of conventional chest radiography to detect 
pathophysiologic conditions in asymptomatic patients is relatively low. However, X-ray 
images may always serve as a basis for comparison should perioperative complications occur. 
While there is currently no recommendation for preoperative chest radiography for patients 
with an American Society of Anesthesiologists score 1–2, regardless of the patient’s age, it is 
indicated for patients who: 
• Suffer from severe chronic obstructive pulmonary disease 
• Developed yet unknown pulmonary or cardiac symptoms 
• Have gastrointestinal malignancies (screening for pulmonary metastases) 
 
Advanced diagnostic tests 
After reviewing the results of routine diagnostic tests, the anaesthesiologist will likely request 
additional tests for certain patients or certain medical conditions. Although not indicated for 
standard gastrointestinal surgery, these additional tests can help in the assessment of the 
potential risk for perioperative problems and complications. 
 
Echocardiography 
Preoperative echocardiography should be performed on patients who: 
• Have newly occurring dyspnoea of unknown origin 
• Have known heart insufficiency with symptoms of deterioration 
• Have cardiomyopathy and have undergone preoperative chemotherapy with epirubicin  
 
Carotid Doppler ultrasonography 
Preoperative carotid Doppler ultrasonography should be performed on patients who: 
• Had experienced transient ischemic attack (TIA) or stroke within the preceding 3 
months if the episode had occurred without proper follow-up medical assessment or diagnosis 
• Had experienced TIA or stroke within the preceding 3 months if symptoms of 
deterioration have appeared 
 
Preoperative risk assessment 
Definition of “high risk” 
The definition of being “high risk” for poor outcome after surgery is nebulous, as it is 
influenced by many variables that vary from patient to patient and from one surgical procedure 
to another. The surgeon and anaesthesiologist need to jointly evaluate the potential 
perioperative risk for each patient and the intended procedure.  
 
Risk scores 
In an attempt to facilitate perioperative risk assessment, a variety of scoring systems have been 
developed that incorporate the patient’s age and comorbidities and the complexity of the 
surgical procedure. Well-known systems include the Physiological and Operative Severity 
Score for the Enumeration of Mortality and Morbidity and the Estimation of Physiologic 
Ability and Surgical Stress score. However, both systems indicate a general risk for 
complications and do not specify or pinpoint any specific complication. Accordingly, their 
implementation into routine clinical practice has proven to be difficult. Data from our 
University Medical Center suggest that the subjective opinion (“gut feeling”) of the surgeon is 
a good predictor of postoperative outcome, especially in nonemergency surgery. 
More recently, a risk calculator for colorectal surgery has been developed by the National 
Surgical Quality Improvement Program registry of the American College of Surgeons. After a 
patient's variables are entered, the risk probabilities for adverse outcome are calculated. 
However, only registry members can access the calculator, and it is not clear whether this US 
hospital-based tool is applicable to European institutions. 
 
Cardiac risk evaluation 
Overall, gastrointestinal surgery is associated with a medium cardiac risk. However, due to an 
ageing population, an increasing incidence of coronary artery disease and the increasing 
complexity of surgical procedures, postsurgical cardiac complications are now a leading cause 
of morbidity and mortality. Particularly cardiac insufficiency is emerging more and more as a 
risk factor for perioperative adverse outcome, even compared with cardiac ischemia. 
Comorbidities that increase the cardiac risk for patients undergoing gastrointestinal surgery 
include: 
• Coronary artery disease 
• Heart insufficiency 
• Severe aortic stenosis 
• Peripheral artery disease 
• Cerebrovascular insufficiency 
• Renal failure 
• Diabetes mellitus 
Because both the assessment of these cardiac risk factors and their clinical interpretation are 
complicated, patients with diverse cardiac risk factors, acute symptoms of a cardiac disease or 
reduced physical fitness should be referred for consultation with an experienced cardiologist. 
 
 
Pulmonary risk evaluation 
Late postoperative pulmonary complications are the second-leading cause of morbidity and 
mortality after major surgery. For this reason, preoperative optimisation of the patient’s 
physical condition and medication is important. Although most of these risk factors cannot be 
circumvented, they must be kept under consideration. 
 
Medication 
Because the abrupt discontinuance of certain drugs may cause severe problems, a detailed 
medical history of the patient’s medication is very important. In general, cardiovascular 
medication should be continued. Clear liquid intake (e.g. water or tea but not milk) is allowed 
until 2 h before anaesthesia, and solid food intake is recommended for up to 6 h prior to 
anaesthesia, so continuing medication usually does not create problems. 
Beta-adrenergic blockers 
Beta-adrenergic blockers are frequently used in the perioperative management of patients with 
cardiac disease due to their favourable effect on the supply and demand ratio of myocardial 
oxygen. Although still under debate, it is currently recommended that all patients who are 
already receiving beta-adrenergic blockers continue them perioperatively. Abrupt 
discontinuation can cause unstable angina, tachyarrhythmia, myocardial infarction and sudden 
death. If a patient who is scheduled for elective gastrointestinal surgery requires a new 
prescription, it should be started at least 1 month before the procedure to allow for dose 
adjustment. 
Diuretics 
Diuretics should not be used on the day of surgery because this may increase the risk of 
intraoperative hypovolaemia. However, it is strongly recommended that their intake be 
continued postoperatively, especially for patients who have heart failure. 
Metformin 
The relevance of the oral anti-diabetic drug metformin for inducing lactic acidosis has been 
controversially discussed in the literature. Regardless, it is recommended that its intake be 
stopped 48 h prior to the surgery. 
 
Acetylsalicylic acid and thienopyridine derivatives 
Anti-platelet therapy (usually 100 mg of acetylsalicylic acid daily) is standard for most patients 
with coronary artery disease. The 2009 European Society of Cardiology guidelines suggest that 
to reduce the risk of stent thrombosis and myocardial infarction, patients with a coronary bare 
metal stent (BMS) or a drug-eluting stent (DES) should receive anti-platelet therapy with both 
acetylsalicylic acid and a thienopyridine derivative (i.e., clopidogrel or ticlopidine) for 1 month 
(BMS) or 12 months (DES) after stent placement. 
                    For patients who currently receive anti-platelet therapy and are scheduled for 
gastrointestinal surgery, the following wait times until surgery are recommended: 
• After percutaneous transluminal coronary angioplasty without stent implantation: 2 
weeks 
• After BMS implantation: 6 weeks, but 3 months preferred 
• After DES implantation: 1 year 
For high-risk cardiac patients (i.e. patients with recent acute coronary syndrome, recurrent 
angina pectoris or recent surgical and conservative coronary intervention) who require major 
surgery that cannot be postponed, thienopyridine derivatives should be stopped 7–10 days 
before the surgery, whereas acetylsalicylic acid should be continued during the entire 
perioperative period. This recommendation also applies to patients who require an epidural 
catheter. 
 
L-Dihydroxyphenylalanine 
L-Dihydroxyphenylalanine is the most frequently prescribed drug for Parkinson’s disease. 
Because of its relatively short half-life, it should be continued during the entire perioperative 
period, as interrupting the medication can result in a life-threatening complication known as 
neuroleptic malignant-like syndrome, which is associated with fever, confusion and elevated 
concentrations of muscle enzymes. 
Pacemaker or implantable cardioverter/defibrillator 
An increasing number of patients who are referred to surgery have a PM or ICD. For these 
patients, the respective PM/ICD pass must be available to health care providers at any time 
during the patient’s hospital stay. Potential electromagnetic interferences during surgery 
require certain safety arrangements for the patient. Unfortunately, evidence-based and 
uniformly accepted guidelines are lacking, and the large number of manufacturers and systems 
makes general safety recommendations extremely difficult.  
 
Mechanical bowel preparation 
The mechanistic rationale for MBP prior to gastrointestinal surgery is to clean the large bowel 
of faeces, thereby reducing the probability of infection after colorectal resection and protecting 
a colorectal anastomosis. However, several prospective randomised trials have demonstrated 
that the outcome of patients who are scheduled for colorectal surgery is not significantly 
different for those who undergo MBP and those who do not. In addition, extensive MBP may 
induce abdominal discomfort, nausea and pain; it may impair postoperative oral nutrition, and 
it may result in electrolyte imbalance and dehydration. For these reasons, extensive MBP is not 
recommended any more. 
The fast-track approach, however, is based primarily on open colorectal surgery, and it remains 
to be demonstrated whether avoidance of MBP can be directly translated into the laparoscopic 
setting, which is becoming more common for elective colorectal surgery.  
 
Early oral nutrition 
Early oral nutrition is recommended for non-emergency gastrointestinal surgery. An earlier 
practice had been temporary starvation; the rationale was to prevent postoperative nausea and 
to protect the surgical intestinal anastomosis from mechanical stress. However, several clinical 
trials failed to demonstrate a clear benefit for this practice, and early nutrition is now standard 
practice. Because postoperative nausea will prevent oral nutrition and hence limit early 
recovery and encourage postoperative ileus, nausea and vomiting should be treated with 
serotonin antagonists, low-dose dexamethasone, droperidol or dimenhydrinate. 
 
Early detection of complications 
The final important aspect of postoperative care is the early detection of complications. Elderly 
patients in particular are at increased risk for developing complications, mainly due to their 
reduced physiologic reserves, multiple (age-related) comorbidities, polypharmacy and a 
frequently altered response to commonly used drugs (altered pharmacodynamics and 
pharmacokinetics). Because only a small group of patients accounts for the majority of 
postoperative morbidity and mortality after gastrointestinal surgery, it is crucial that these high-
risk patients be identified. In addition, for these patients, extra efforts must be made to prevent 
potential complications and to identify actual complications as early as possible. 
For elderly patients, a complication termed postoperative cognitive decline (POCD) appears to 
be an increasing problem. In contrast to postoperative delirium, which is defined as confusion 
and altered consciousness that lasts for days, POCD primarily effects memory and executive 
function and may last for weeks or months. It is unclear how this complication can be 
prevented, if at all. 
CONCLUSION 
Standard perioperative management in elective gastrointestinal surgery has advanced 
significantly in the last decade. As a truly multidisciplinary approach, it involves close 
interaction between the disciplines of surgery, anaesthesiology and intensive care medicine 
throughout the preoperative, intraoperative and postoperative phases. Major improvements 
have been based on evidence, and their implementation into routine clinical practice has 
enabled increasingly complex surgical procedures for an ageing patient population with 
significant comorbidities. For these reasons, major gastrointestinal surgery can now be safely 
performed with acceptable morbidity and mortality rates. 
 
 
 
 
 
                                         MATERIALS AND METHODS 
1. Patients subjected to this study were taken from surgical units of Government Rajaji 
Hospital, Madurai over a period of 6 months from  January 2016 to  June 2016. 
 
2. 50 patients underwent Gastrointestinal anastomosis surgeries (34 males and 16 females) 
for various abdominal conditions. 
 
3. Factors such as age, sex, weight loss, anorexia, vomiting, diarrhea, fat wasting, muscle 
wasting, oedema and ascites were taken into account. 
 
4. Patients were investigated with Haemoglobin, Serum Protein, Complete blood count, 
blood sugar, renal function test and ultrasonogram of abdomen and pelvis. 
 
5. Patients were classified into 3 groups - A, B & C, based on their preoperative nutritional 
status using Subjective Global Assessment Score. 
 
6. Patients were operated upon by experienced surgeons and Gastrointestinal anastomosis 
surgeries were done for their conditions. 
 
7. The incidence of post-operative morbidity was assessed in each group of patients and its 
correlation with preoperative nutritional status as predicted by the SGA score was observed. 
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                                    ELIGIBILITY CRITERIA 
 
 
A. Inclusion criteria: 
1. Patients - Age between 16 and 80 years in both sexes. 
2. All patients undergoing elective Gastrointestinal surgeries involving bowel anastomosis. 
3. Patients who consented for inclusion in the study according to designated proforma. 
 
 
 
 
B. Exclusion criteria: 
1. Patients undergoing emergency Gastrointestinal surgeries and major elective surgeries 
other than Gastrointestinal surgeries. 
2. Patients who refused to give informed written consent. 
 
 
 
 
 
 
OBSERVATION OF THE STUDY 
          
The study included 50 patients of whom 39 were male patients and 11 were female patients. 
The patients were attending the surgical out-patients department of Government Rajaji 
Hospital, Madurai. 
Among the 50 cases, the common age group of patients was between 46-60 years followed by 
patients between 31-45 years. Least incidence of requirement of surgery was found in young 
patients below 30 years of age. 
 
 The age distribution of the patients taken up for anastomotic surgeries is shown in table 
below: 
 
 
 
 
 
 
 
 
 
AGE No. of 
Cases 
% 
<30 6 12.00 
31—45 13 26.00 
46—60 21 42.00 
>60 10 20.00 
Total 50 100.00 
The number of male patients requiring anastomosis surgeries in the study group was 39 as 
compared to 11 female patients, which constitutes 78% of males and 22% of females showing a 
male predilection of these diseases.  
  
 
 
 
 
 
 
The commonest symptom occurring in the patients included in the group was weight loss 
occurring in more than 80% of patients: 
 
 
 
 
 
 
AGE No. of 
Cases 
% 
Male 39 78.00 
Female 11 22.00 
Total 50 100.00
Weight Loss No. of 
Cases 
% 
Yes 41 82.00 
No 9 18.00 
Total 50 100.00
The least common finding in the patients was the presence of ascites which was seen in less 
than 15% of patients. 
 
 
 
 
 
 
 
Other common symptoms in the patients were: 
        Anorexia which was seen in 72% of patients. 
        Fat loss seen in 54% of patients. 
        Vomiting which occurred in 48% of patients. 
 
 
 
 
Ascites No. of 
Cases 
% 
Yes 7 14.00 
No 43 86.00 
Total 50 100.00
The various diagnoses for which patients were admitted are as follows which shows carcinoma 
of stomach to be the commonest diagnosis in these patients: 
Error! Not a valid link. 
 
 
The following table shows the various procedures performed in the study group which shows 
that Gastrojejunostomy and Right Hemicolectomy to be the commonest procedures that were 
performed for the patients: 
 
Procedure No. of Cases % 
APR 3 6.00 
Coloplasty 1 2.00 
Distal Gastrectomy 6 12.00 
Gastrojejunostomy 7 14.00 
Ileotransverse anas 2 4.00 
Limited resection 1 2.00 
Low anterior resec 1 2.00 
Lt. Hemicolectomy 2 4.00 
Oesophagojejunos 3 6.00 
Palliative bypass 3 6.00 
Resection anastom 6 12.00 
Rt. Hemicolectomy 7 14.00 
Stoma takedown 4 8.00 
Total Gastrectomy 2 4.00 
Whipple's procedu 2 4.00 
Total 50 100.00 
 
The study did not reveal any significant difference in the occurrence of morbidity in males and 
females. The following table shows the absence of any significant sex predilection in the 
occurrence of morbidity in the patients: 
Error! Not a valid link. 
 
 
 
 
 
 
 
 
Sex vs 
Morbitity 
Yes No Total 
MALE 18 21 39 
FEMALE 5 6 11 
Total 23 27 50 
BMI vs 
Morbidity 
Yes No Total 
<18.5 16 0 16 
>18.5 7 27 34 
Total 23 27 50 
 
 
The study shows a significant correlation between low BMI and postoperative morbidity with 
all patients developing morbidity 
The observation made during the study regarding the correlation of SGA score and 
postoperative morbidity showed that patients belonging to Group A had a better post-operative 
outcome when compared to patients in Group B who had a significantly better outcome 
compared to patients in Group C: 
Error! Not a valid link. 
 
 
 
 
                            DISCUSSION OF THE STUDY 
      In the study conducted, 50 patients were included out of which 39 patients were male and 
11 patients were female patients.  
       Patients most commonly belonged to 46-60 years age group which included 42% of 
patients followed by 26% of patients belonging to 31-45 years age group. The least occurrence 
was seen in less than 30 years age group. 
       The commonest symptom that occurred in the patients was weight loss which was seen in 
41 out of 50 patients constituting  82% of the study group. 
       Other clinical features included anorexia seen in 72% of patients, fat loss in 54%, vomiting 
seen in 48%, diarrhea seen in 40%, muscle wasting in 28%, oedema in 18%, least common 
being ascites seen in 14% of patients. 
       
         The incidence of vomiting was seen to be higher in patients having upper gastrointestinal 
pathology while diarrhea was more common in patients with colonic and distal small intestinal 
disorders. 
          The commonest condition seen in the patients was Carcinoma Stomach which was the 
diagnosis in 8 patients out of 50, constituting 16% of the study group. 
          The most frequently performed procedures were Gastrojejunostomy and Right 
Hemicolectomy which were performed in 7 patients each, constituting  14% each of the total 
study group. 
         There was no significant difference in the incidence of postoperative morbidity in male 
and female patients.  
       
         
 
  
 
                   
  
 
 
The importance of preoperative BMI in the study group has been observed to be significant 
with all patients belonging to low BMI of less than 18.5 developing complications 
postoperatively compared to less than 20% of patients with normal BMI developing morbidity. 
 
 
 
 
 
         Coming to the most important aspect of the study which is the Subjective Global 
Assessment score: out of 14 patients who belonged to the well nourished SGA Group A, only 1 
patient was found to have developed postoperative morbidity, namely requirement of 
postoperative blood transfusion. 
          One third of patients, namely 7 out of 21 patients belonging to the moderately nourished 
Group B, developed postoperative complications. Out of the 7 patients, 3 of them required 
blood transfusions, 2 patients required fresh frozen plasma and albumin transfusion, 1 patient 
required ventilator support and 1 patient developed anastomotic leak which was managed 
conservatively. 
          In the study group, 15 patients belonged to SGA Group C or the poorly nourished group. 
Of these, all 15 patients developed postoperative morbidity and required prolonged intensive 
care and hospital stay.  
          8 out of 15 patients required both blood and fresh frozen plasma transfusions for a 
minimum of 3 days and a maximum of 5 days. 3 patients developed postoperative anastomotic 
leak of which 2 patients had to be reoperated and stoma was created. 4 patients required 
ventilatory support for a minimum of 2 days and maximum of 6 days. 10 out of these 15 
patients developed postoperative wound infect 
 
 
 
 
 
  
 
                                         CONCLUSION 
         
              The study was successfully completed and the Subjective Global Assessment score 
proved to be 100% successful in predicting postoperative morbidity in poorly nourished 
patients. 
                   The study shows the correlation between preoperative nutritional status of patients 
undergoing gastrointestinal anastomotic surgeries and the corresponding postoperative 
morbidity in these patients. 
                  Thus, the Subjective Global Assessment score is a valuable tool in predicting the 
occurrence of postoperative complications in patients whose preoperative nutritional status is 
below optimum level. Implementing this scoring system routinely in our wards prior to taking 
up patients for major surgeries and optimizing the nutritional status (improving status from 
Group C to Group A) with preoperative nutritional support  will reduce the incidence of 
adverse outcomes in patients and will consequently reduce the health related monetary as well 
as resource expenditure of the State. 
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                                                              PROFORMA  
 
Name:                                                         Age:                                               Sex: 
IP No:                                                        Contact no.: 
DOA: 
 
Chief Complaints   
 
History 
 
Examination Findings 
Pulse : 
BP : 
 
Investigations 
Hb 
Serum Protein 
USG Abdomen & Pelvis : 
 
Final diagnosis 
Procedure planned 
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Subjective Global Assessment 
Name:   
Date:   
 
Medical History 
 
 
A 
 
B 
 
C 
 
WEIGHT 
 
Usual weight…………… 
 
Current weight……… 
   
Wt change past 6 months Amount weight loss……. % weight loss……….    
0-<5% loss   *   
5-10% loss    *  
>10% loss     * 
 
Weight change past 2 weeks 
  
Amount………………. 
   
No change; normal weight   *   
Increase to within 5%   *   
Increase (1 level above)   * *  
No change, but below usual wt    *  
Increase to within 5-10%    *  
Decrease  
 
    * 
 
DIETARY INTAKE 
     
No change; adequate   *   
No change; inadequate    *  
 
Change 
  
Duration of change…………... 
   
Suboptimal diet    *  
Full liquid    *  
Hypocaloric liquid     * 
Starvation      * 
 
Intake borderline; increasing 
   
* 
  
Intake borderline; decreasing    *  
Intake poor; no change    * * 
Intake poor; increasing    *  
Intake poor; decreasing 
 
    * 
 
GASTROINTESTINAL SYMPTOMS 
     
 Frequency (never, daily, no. of times/week) Duration (<2wk, >2wk)    
Nausea ……………………      ………………..    
Vomiting  ……………………      .……………….    
Diarrhoea  ……………………      ………………...    
Anorexia  ……………………      ………………...    
 
None; intermittent 
   
* 
  
Some (daily >2 week)    *  
All (daily >2 week) 
 
    * 
 
FUNCTIONAL CAPACITY 
     
No dysfunction  Duration of change …………….. *   
Difficulty with ambulation/normal activities    *  
Bed/chair-ridden     * 
 
Change past 2 week 
     
Improved    *   
No change    *  
Regressed     * 
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Physical examination 
 
 
A 
 
B 
 
C 
 
SUBCUTANEOUS FAT 
   
Under the eyes 
 
Slightly bulging area  Hollowed look, 
depression, dark 
circles 
Triceps  
 
Large space between 
fingers 
 Very little space 
between fingers, or 
fingers touch 
Biceps  
 
Large space between 
fingers 
 Very little space 
between fingers, or 
fingers touch 
 
MUSCLE WASTING 
   
Temple  
 
Well-defined 
muscle/flat 
Slight depression Hollowing, 
depression 
Clavicle 
 
Not visible in Males; 
may be visible but not 
prominent in females 
Some protrusion; 
may not be all the 
way along 
Protruding/prominent 
bone 
Shoulder 
 
Rounded No square look; 
acromion process 
may protrude 
slightly 
Square look; bones 
prominent 
Scapula/ribs  
 
Bones not prominent; 
no significant 
depressions 
Mild depressions or 
bone may show 
slightly; not all 
areas 
Bones prominent; 
significant 
depressions 
Quadriceps  
 
Well rounded; no 
depressions 
Mild depression Depression; thin 
Calf 
 
Well developed  Thin; no muscle 
definition 
Knee 
 
Bones not prominent  Bones prominent 
Interosseous muscle between 
thumb and forefinger 
Muscle protrudes; 
could be flat in females 
 Flat or depressed 
area 
 
OEDEMA (related to malnutrition) 
 
 
No sign 
 
Mild to moderate 
 
Severe 
 
ASCITES (related to malnutrition) 
 
 
No sign 
 
Mild to moderate 
 
Severe 
 
OVERALL SGA RATING 
 
 
A 
 
B 
 
C 
 
Adapted from: Detsky et al., 19948; Baxter Healthcare Corporation, 1993; McCann, 1996 
(Ferguson, Bauer, Banks, Capra, 1996)© 
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sno name ipno age sex weighlos anorexia vomit diarrhea fatloss
1 Valli 1079678 60 2 Y Y N N Y
2 Andavar 1077960 55 1 Y Y Y N N
3 Chellam 1078808 61 1 Y Y N N N
4 Selvarani 1078838 44 2 N Y N Y N
5 Ponni 1080117 26 2 Y N Y N N
6 Karthigaisamy 71776 45 1 Y N Y N N
7 Irulayee 1078806 65 2 Y Y N Y N
8 Murugan 1080111 40 1 Y Y Y N N
9 Kaliappan 1074670 70 1 Y Y Y N N
10 Noor Mohamed 1080159 64 1 Y Y N Y Y
11 Parameswaran 1080107 46 1 Y Y N Y N
12 Jayalakshmi 243410 34 2 Y Y Y N N
13 Muthukarungu 1078689 38 1 Y Y Y N N
14 Rajamani 1082652 77 1 Y Y N Y Y
15 Boominathan 1071892 55 1 N Y N Y N
16 Panchasaram 1076226 49 1 Y N N N N
17 Kannan 14965 42 1 Y Y N Y N
18 Jayaraj 1084129 18 1 N Y Y Y N
19 Radhakrishnan 1085477 50 1 Y Y Y N N
20 Ammaponnu 1085339 56 2 Y N Y N N
21 Kaliyamurthy 1082538 33 1 Y N N Y N
22 Muruganandam 1086921 42 2 Y N N Y N
23 Silambayee 1087024 57 2 Y Y Y N Y
24 Karuppaiya 1087836 47 1 Y Y N Y N
25 Parthasarathy 47438 54 1 Y Y Y N Y
26 Prakash 1086965 42 1 N Y Y N Y
27 Andi 1088631 49 1 N N N Y Y
28 Ayyappan 47414 60 1 Y Y N Y Y
29 Sekaramoorthy 1089848 52 1 Y Y Y N Y
30 Saravanan 1090470 20 1 Y Y N N Y
31 Ramar 1083349 62 1 Y Y N N Y
32 Valli 1090296 46 2 N Y N Y N
33 Perumal 1091879 61 1 Y Y N N Y
34 Rajendran 1091173 29 1 N Y Y N Y
35 Nagarajan 1092642 53 1 Y Y N Y Y
36 Kassammal 1094721 35 2 Y N Y N Y
37 Sivakumar 47433 41 1 Y N N N Y
38 Velusamy 1094100 63 1 Y N N Y Y
39 Nagarajan 1094177 38 1 Y Y N Y N
40 Subbaiya 1072585 62 1 Y Y Y N Y
41 Karupaiya 1094984 50 1 N Y Y N Y
42 Balamurugan 1091080 54 1 Y N Y Y N
43 Prithviraj 1092543 55 1 Y N N N Y
44 Saravanan 1096656 20 1 Y N Y N Y
45 Thangapandi 1095100 49 1 Y Y N Y Y
46 Bharathimuthu 1096771 48 2 Y Y Y N Y
47 Ranjith 1098188 35 1 Y Y Y N Y
48 Nagapandi 1099564 51 1 Y Y Y N Y
49 Govindan 1100751 29 1 N N N Y Y
50 Narayanan 1120536 61 1 Y Y Y N Y
muswast oedema ascites diagnos proce bmi sga morbidit
Y Y 2 carcinoma caecum Rt. Hemicolectomy 17.9 3 Y
N Y 2 carcinoma stomach Distal Gastrectomy 19.3 2 N
Y Y 1 periampullary carcinoma Palliative bypass 16.4 3 Y
N N 2 ileocaecal tb Limited resection 21.2 1 N
N N 2 cicatrized duodenal ulcer Gastrojejunostomy 23.4 1 N
N N 2 GIST Distal Gastrectomy 22.7 1 N
Y Y 2 carcinoma rectum APR 17.1 3 Y
N N 2 carcinoma oesophagus Oesophagojejunos 18.8 2 N
N N 2 periampullary carcinoma Whipple's procedu 18.1 2 Y
Y N 1 hepatic flexure growth Rt. Hemicolectomy 17.5 3 Y
N N 2 ileal interloop abscess Resection anastom 22.6 1 N
Y N 2 oesophageal stricture Coloplasty 17.3 3 Y
N N 2 carcinoma stomach Total Gastrectomy 19.9 2 N
Y Y 2 carcinoma rectum APR 16.8 3 Y
N N 2 descending colon growth Lt. Hemicolectomy 20.6 1 N
N N 2 post-ileostomy status Stoma takedown 22.5 1 N
N Y 2 caecal carcinoma Rt. Hemicolectomy 19.7 2 Y
N N 2 meckel's diverticulum Resection anastom 23.2 1 N
Y N 2 carcinoma stomach Total Gastrectomy 17.4 3 Y
N N 2 cicatrized duodenal ulcer Gastrojejunostomy 21.6 2 N
N N 2 ileal stricture Resection anastom 20.5 2 N
N N 2 post-hartmann's procedure Stoma takedown 20.7 1 N
N N 1 pancreatic carcinoma Palliative bypass 17.9 3 Y
N N 2 ileocaecal tb Rt. Hemicolectomy 20.1 2 N
N N 2 carcinoma stomach Distal Gastrectomy 21.2 2 Y
N N 2 cicatrized duodenal ulcer Gastrojejunostomy 19.9 1 N
N Y 1 ascending colon growth Ileotransverse anas 18.1 3 Y
Y N 2 carcinoma rectum Low anterior resec 17.2 3 Y
Y N 1 carcinoma oesophagus Oesophagojejunos 17.6 3 Y
N N 2 periampullary carcinoma Whipple's procedu 19.3 2 Y
N N 2 hepatic flexure growth Ileotransverse anas 20.5 2 N
N N 2 carcinoma rectosigmoid jn. Lt. Hemicolectomy 21.7 1 Y
Y Y 1 ca - head of pancreas Palliative bypass 18.2 3 Y
N N 2 carcinoma stomach Distal Gastrectomy 19.8 2 Y
Y Y 2 carcinoma rectum APR 17.9 3 Y
N N 2 cicatrized duodenal ulcer Gastrojejunostomy 20.4 2 N
N N 2 post-ileostomy status Stoma takedown 22.6 1 N
Y N 2 caecal carcinoma Rt. Hemicolectomy 19.2 2 N
N N 2 carcinoid appendix Rt. Hemicolectomy 21.5 2 Y
Y N 1 carcinoma stomach Gastrojejunostomy 18.1 3 Y
N N 2 cicatrized duodenal ulcer Gastrojejunostomy 21.2 1 N
N N 2 jejunal stricture Resection anastom 20.7 2 N
N N 2 post-hartmann's procedure Stoma takedown 22.6 1 N
N N 2 ileal band Resection anastom 21.3 2 N
N N 2 ileocaecal tb Rt. Hemicolectomy 18.6 2 Y
N N 2 carcinoma stomach Distal Gastrectomy 19.4 2 N
N N 2 cicatrized duodenal ulcer Gastrojejunostomy 20.2 2 N
N N 2 carcinoma stomach Distal Gastrectomy 19.1 2 N
N N 2 enterogenous cyst Resection anastom 21.7 1 N
Y N 2 carcinoma oesophagus Oesophagojejunos 16.9 3 Y
